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Résumé 
            La santé folliculaire est déterminée par un nombre de facteurs endocriniens, 
paracrines et autocrines. Les gonadotrophines hypophysaires sont les principaux moteurs 
du développement du follicule, mais leurs actions sont modulées localement par les 
hormones et des facteurs de croissance. Les glycoprotéines de la famille des WNTs 
représentent une grande famille de molécules impliquées dans différentes voies de 
signalisation. Ils sont sécrétés dans le but de moduler et coordonner la réponse des 
follicules aux gonadotrophines, et leurs activités sont indispensables à la fonction 
ovarienne et à la fertilité féminine. Les WNTs sont généralement classés en fonction de la 
(des) voie(s) qu’ils activent. Le rôle des membres de la voie canonique WNT et de ses 
composants tels que CTNNB1, WNT4, WNT2, FZD1 et FZD4 est bien établi au cours du 
développement du follicule chez les rongeurs. Un rôle similaire des WNTs dans les 
espèces mono-ovulatoires demeure essentiellement inconnu. De plus, le rôle des WNT 
non canoniques dans l'ovaire de rongeurs est méconnu. 
Les objectifs de cette thèse sont (1) d'élucider la régulation hormonale de 
l'expression de WNT5A et le rôle physiologique de WNT5A dans les cellules de la 
granulosa bovine in vitro et (2) d'identifier les rôles physiologiques de WNT5A dans 
l'ovaire de souris par inactivation génique conditionnelle. Chacun de ces objectifs a mené 
à la publication d’un article à partir des résultats obtenus au cours de cette thèse.  
Dans le premier article, le rôle de WNT5A dans les cellules de la granulosa bovine 
a été étudié in vitro. Nous avons constaté que WNT5A est un régulateur négatif de la 
stéroïdogenèse stimulée par la FSH issue des cellules de la granulosa, et qu'il agit en 
supprimant l'activité de signalisation des WNTs canoniques tout en induisant la voie de 
signalisation MAPK8/JUN.  
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Dans le deuxième article, afin d’examiner le rôle de deux WNTs non-canoniques, 
WNT5A et WNT11, à différents stades de développement folliculaire, nous avons généré 
des modèles de souris knock-out conditionnels ciblant les cellules de la granulosa pour 
chacun de ces WNTs. Les résultats obtenus ont permis de mettre en évidence que WNT5A 
est nécessaire pour assurer la fertilité normale chez la femelle, le développement 
folliculaire et la stéroïdogenèse ovarienne. Il est aussi un antagoniste de la réponse aux 
gonadotrophines, agissant par l’intermédiaire de la suppression de la signalisation 
canonique des WNTs. Chez les souris knock-out pour WNT11, nous ne constatons aucun 
défaut important dans la fertilité des femelles. 
L’ensemble de notre travail met en évidence que WNT5A est essentiel pour le 
développement normal du follicule et qu’il agit pour inhiber la différenciation des cellules 
de la granulosa. En résumé, nous avons fourni une étude novatrice et approfondie, utilisant 
plusieurs modèles et techniques pour déterminer les mécanismes par lesquels WNT5A 
régule le développement des follicules. 
 
Mots clés: WNT5A, développement folliculaire, cellules de la granulosa, stéroïdogenèse 
ovarienne, vache, souris knock-out conditionnel. 
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Abstract 
Follicle health is determined by an array of endocrine, paracrine and autocrine 
factors. Pituitary gonadotropins (LH and FSH) are major drivers of follicle development, 
but their actions are modulated by local hormones and growth factors. The WNT family of 
secreted glycoproteins are signaling molecules that act to modulate and coordinate 
follicular responses to the gonadotropins, and whose activities are indispensable for 
ovarian function and female fertility. WNTs are normally categorized according to 
pathway(s) via which they signal. The role of canonical WNT members and components 
such as CTNNB1, WNT4, WNT2, FZD4 and FZD1 is well established during follicle 
development in rodents. Whether WNTs play similar roles in monovular species remains 
essentially unknown. Moreover, the role of non-canonical WNTs in the rodent ovary is 
unclear.  
The objectives of the present thesis were (1) to elucidate the hormonal regulation 
of WNT5a expression and the physiological role of WNT5a in bovine granulosa cells in 
vitro and (2) to identify the physiological roles of WNT5a in the mouse ovary by 
conditional gene inactivation. 
The results of this thesis are presented in two articles. In the first article, the role of 
WNT5a in bovine granulosa cells was investigated in vitro. We found that WNT5A is a 
negative regulator of FSH-stimulated granulosa cell steroidogenesis, and that it acts by 
suppressing canonical WNT signaling activity and inducing the noncanonical 
MAPK8/JUN pathway. In the second article, we generated granulosa-specific knockout 
mouse models to examine the roles of two non-canonical WNTs, WNT5a and WNT11, in 
different stages of the follicular development. Our results showed that WNT5a is required 
for normal female fertility, follicle development and ovarian steroidogenesis, and is an 
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antagonist of gonadotropin responsiveness that acts via the suppression of canonical WNT 
signaling. However we did not observe any significant defects in fertility of WNT11 
knockout mice.  
Together, our work demonstrates that WNT5a is essential for normal follicle 
development and acts to inhibit differentiation in granulosa cells. In overview, we 
provided a novel and comprehensive investigation, using multiple models and techniques, 
to determine the mechanisms by which WNT5a regulates follicle development.  
 
Key words: WNT5a, follicle development, granulosa cells, ovarian steroidogenesis, cow, 
conditional knockout mouse. 
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Introduction 
Follicles are the basic functional units of mammalian ovaries and are composed of 
germ cells (oocyte) and somatic cells (granulosa, theca and stromal cells) (Hsueh et al., 
2015). Follicle development initiates during fetal life (in humans) or after birth (in 
rodents) when primordial follicles are formed. Once follicles start to grow, the activated 
primordial follicle composed of a single layer of small granulosa cells surrounding the 
primordial oocyte develops into a primary, secondary and eventually an antral follicle 
(Richards and Pangas, 2010). The process of the follicular maturation, known as 
folliculogenesis, is mainly under control of the gonadotropins (FSH (follicle stimulating 
hormone) and LH (luteinizing hormone)), which are secreted from the anterior pituitary 
(Richards et al., 2002). Besides the gonadotropins, ovarian follicle growth is controlled by 
the production of intraovarian growth regulatory factors that act by autocrine, paracrine 
and intracrine mechanisms (Richards, 1994).  
Members of WNT family of signaling molecules have been shown to impact 
ovarian cell function and follicle organization. WNTs are secreted signaling molecules 
that act locally to control different developmental processes including cell proliferation 
and differentiation (Cadigan and Nusse, 1997). Canonical and non-canonical WNTs 
transduce their signal via Frizzled (FZD) family receptors to activate diverse signaling 
cascades (Slusarski et al., 1997), which will be further detailed in the end of chapter 1 of 
this thesis. Recent reports have suggested roles for canonical WNT signaling in the adult 
ovary. Indeed, canonical WNTs are required for normal antral follicle development and 
act by regulating granulosa cell functions including steroidogenesis and proliferation 
(Boyer et al., 2010a, Boyer et al., 2010b, Wang et al., 2010). Whether WNTs play similar 
roles in monovular species remains essentially unknown. Likewise, little attention has 
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been paid to the potential roles of non-canonical signaling pathways in the ovary of mono- 
and polyovular species. 
This thesis describes studies that took advantage of both cow and mouse models to 
investigate the roles of non-canonical WNT signaling in the female fertility. The bovine 
species is a mono-ovulatory species and serves as a suitable model for studying human 
reproduction, as the two species have a similar length of gestation and typically release 
one oocyte at ovulation (Fortune, 1994). The rodent is a widely used model for studying 
reproduction for several reasons, including cost, ease of maintenance and a short 
generation interval. Transgenic mouse models have been effective and beneficial in 
understanding female reproduction (Matzuk and Burns, 2012).  
Novel findings in this thesis may provide new insight into the roles and 
mechanisms of action of the non-canonical WNT pathways in granulosa cells. This thesis 
may also provide new clues regarding the etiology of various ovarian disorders. 
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Chapter 1. Literature review 
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1. Ovaries 
Gametogenesis is the result of a coordinated signaling network between the 
gonads, pituitary, and hypothalamus. The ovaries are gonads that often found in pairs as 
part of the vertebrate female reproductive system and are crucial structures for the survival 
of the species (McDonald and Pineda, 1989). The germinal components (originating from 
primordial germ cells) start to colonize the gonadal primordia after migration from the 
yolk sac. The gonadal primordia forms a paired thickening of the coelomic epithelium that 
lines the ventral–medial surface of the mesonephros (the mid-region of the embryonic 
kidney), and arises within the intermediate mesoderm between the pronephros (initial 
kidney) and metanephros (the definitive kidney) on embryonic day 34 in human (Oktem 
and Oktay, 2008). The ovary is composed of two types of cells; germ cells (oocytes) and 
somatic cells (granulosa, thecal, and stromal), whose interactions dictate formation of 
follicles, development of both oocytes and somatic cells as follicles and  ovulation 
(Richards and Pangas, 2010). 
The ovary has two fundamental physiological roles. First is the gametogenic 
function that is responsible for the differentiation and release of a mature oocyte for 
fertilization. The second is the endocrine function that is essential for follicle 
development, menstrual/estrous cyclicity, and maintenance of the reproductive tract and 
its function. These two complementary roles are necessary for successful reproduction 
(Barnett et al., 2006). 
 
1.1 Functional and anatomy of ovarian follicle structure 
Growth and development of the somatic and germ cell compartments of the 
ovarian follicle occur in a highly coordinated and mutually dependent manner. In 
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mammalian ovaries, the individual graafian=preovulatory follicles consist of layers of 
theca and granulosa cells surrounding the germ cell (Gilchrist et al., 2004). 
From the morphologic standpoint, the ovarian follicle may be classified into three 
major groups that are different in their size, complexity, and responsiveness to circulating 
gonadotropin. Primordial follicles include an oocyte surrounded by a single layer of 
epithelial, flattened granulosa cells with irregularly shaped nuclei. Theca cells are not 
present at this stage of folliculogenesis and they lack a distinct vasculature system.  
Primary follicle contains a small oocyte with a single layer of cuboidal granulosa 
cells. Secondary follicles leave the primary stage and begin growth, but not develop a 
theca layer or antrum cavity. These types of follicles have two or more layer of granulosa 
cells and zona pellucida surrounding the oocyte. Preovulatory or graafian follicles have a 
clearly visible antrum. The zona pellucida (ZP) is formed and two layers of theca cells 
appear in this stage (Figure 1).  
The oocyte pool in the mammalian ovary becomes fixed early in life. The number 
of primordial follicles that undergoing folliculogenesis to reach the mature, 
graafian=preovulatory stage is very low, and most of the follicles are either under a 
process of regression (atresia) or remain as primordial follicles without signs of growth. In 
response to preovulatory gonadotropin surges during each reproductive cycle, the 
dominant(s) graafian=preovulatory follicle ovulates to release the mature oocyte for 
fertilization, whereas the remaining theca and granulosa cells undergo transformation to 
become the corpus luteum (Myers et al., 2004). 
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1.1.1 Oocyte 
An oocyte is a female gametocyte or germ cell and is produced in the ovary during 
gametogenesis. During oogenesis, a primordial germ cell (PGC) undergoes meiosis to 
 
Figure 1. Follicular classification. 
(A) Primordial follicles are defined as an oocyte surrounded by a flat layer of 
granulosa cells. (B) Follicles with cuboidal granulosa cells around the oocyte are 
classified as primary. (C) Secondary follicles are surrounded by more than one layer 
of cuboidal granulosa cells, with no visible antrum. (D) Preovulatory follicles are the 
largest follicles and possess a defined cumulus cell layer. Taken from (Myers et al., 
2004). 
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form an oogonium, which becomes a primary oocyte (McDonald and Pineda, 1989). A 
relatively thick extracellular coat called the zona pellucida (ZP) surrounds the primary 
oocyte. The width of the ZP increases as the oocyte grows. Far from being a static 
structure, the ZP plays an important role in facilitating the interaction of sperm and oocyte 
at the time of fertilization. The ZP first appears as fibrillar material in the space between 
the oocyte and the cuboidal granulosa cells. As oocyte growth continues, the ZP becomes 
a denser and thicker network of connected filaments that completely surrounds the oocyte 
and largely separates it from the granulosa cells. Close contact continues to be maintained 
between the oocyte and surrounding granulosa cells via gap junction complexes within the 
zona until the completion of oocyte maturation (Conner et al., 2005).  
Meiotic arrest of oocytes and cumulus cell expansion with germinal vesicle 
breakdown (GVBD) are signs of oocyte maturation. In mammalian follicles, primary 
oocytes enter meiosis but are arrested at the diplotene stage of prophase I. The oocytes 
stay in this state for months or years until the preovulatory stage. While the oocyte 
progresses through the maturation process in response to the preovulatory dose of LH 
surge, the germinal vesicle of the oocytes in preovulatory follicles undergoes GVBD, 
which is followed by chromatin condensation and the formation of meiotic spindles. The 
transition from metaphase I (MI) to metaphase II (MII) includes the extrusion of the first 
polar body. The maturing oocyte is the site of phosphorylation events that activate or 
deactivate the proteins involved in the progression of the cell cycle (Chian et al., 2003). 
Generally, meiotic arrest is controlled by the level of cAMP (cyclic adenosine 
monophosphate) in the oocyte. Recently, molecular studies have identified G-protein 
coupled receptors (GPCR) including GPR3 and GPR12, which control cAMP production 
and inhibit meiotic maturation in the oocytes of antral follicles. In fact, oocytes themselves 
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express a receptor that allows these cells to produce their own cAMP (Hinckley et al., 
2005). In addition, AKAPs (PKA anchor proteins) can regulate the cAMP/PKA pathway 
and consequently meiosis in the mammalian ovary (Burton and McKnight, 2007). 
Many of the effects of oocytes on follicular cells can be mimicked by members of 
the transforming growth factor (TGF) superfamily, including TGFβ1 and growth 
differentiation factor 9 (GDF-9) (Li et al., 2000). Genetic disruption of Gdf9 in mice 
causes infertility and abnormal follicle development with arrest at the primary follicle 
stage. Similar to GDF9, GDF-9B (also called bone-morphogenetic factor-15 (BMP-15)) is 
an oocyte-derived growth factor that regulates granulosa cell proliferation and 
differentiation. There is a species-to-species difference in the role of BMP15. Bmp15-null 
mice are sub-fertile, have defects in cumulus-oocte complex (COC) formation and show a 
decrease in ovulation rate (Richards and Pangas, 2010). Mutations of GDF9 and BMP15 
have been found to cause premature ovarian failure in women (Simpson, 2008). 
Oocyte-secreted factors regulate folliculogenesis by modulating a large number of 
processes associated with granulosa cell growth and differentiation, including cumulus 
cell mucification and hyaluronic acid production, cellular proliferation, steroid synthesis 
and luteinization inhibitors (Gilchrist et al., 2004). Experimental ablation of oocytes leads 
to failure of folliculogenesis. Removing oocytes from preovulatory rabbit follicles results 
in spontaneous luteinization (el-Fouly et al., 1970). It has been shown that oocytes secrete 
a potent mitogenic factor(s) that promotes mural granulosa and cumulus cell DNA 
synthesis and cell proliferation. Importantly, this oocyte mitogen(s) interacts with key 
known granulosa cell regulators such as FSH, insulin-like growth factors (IGF-I) and 
androgens, and increase their growth promoting activities (Eppig et al., 1997). Oocytes 
also promote the primary to secondary and preantral to antral follicle transitions, granulosa 
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cell proliferation, and differentiation before the LH surge, and cumulus expansion and 
ovulation after the LH surge. It appears that oocyte plays a dominant role in this kind of 
communication, and the rate of ovarian follicular development is coordinated by the 
oocyte’s developmental program (Su et al., 2009). 
 
1.1.2 Granulosa and cumulus cells 
As follicles grow and the antral cavity forms, granulosa cells separate into two 
anatomically and functionally distinct subtypes: the cumulus granulosa cells (CC), those 
surrounding and in contact with the oocyte, and the mural granulosa cells (MGC), which 
cover the follicle wall forming an epithelium with the basal lamina (Figure 2). Apart from 
anatomical differences, cumulus cells and MGC are functionally distinct (Albertini et al., 
2001, Eppig et al., 1997).  
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In terms of function, CCs have a high rate of proliferation, low steroidogenic 
capacity, very low LHR (LH receptor) expression and high levels of insulin-like growth 
factor I compare to MGC, and they have the capacity to secrete hyaluronic acid and 
undergo mucification and expansion whereas MGC do not (Li et al., 2000). The 
expression of a variety of growth factors and hormone receptors also differ between MGC 
and CCs. Cumulus cells play an essential role in the normal growth and development of 
the oocyte, whereas MGCs serve a primarily endocrine function and support follicle 
growth. In addition, throughout ovulation, granulosa cells have an endocrine role by 
undergoing terminal differentiation to luteal cells, whereas cumulus cells mucify and are 
Figure 2. Antral follicle structure with different granulosa cell types surrounding 
the oocyte. 
(http://lib.znate.ru/docs/index-236482.html?page=4) 
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ovulated with the oocyte, permitting ovum pickup and the sperm acrosome reaction (Li et 
al., 2000). Recently, many functional genomics studies have analyzed the importance of 
different genes by Cre/LoxP-mediated conditional deletion in granulosa cells. Two mouse 
strains expressing Cre recombinase (Amhr2-Cre and Cyp19-Cre) have been widely used 
used to target gene inactivation to granulosa cells. Amhr2-Cre is a knock-in of Cre in the 
anti-Mullerian hormone receptor type II locus, which directs Cre expression at early stages 
of follicle development. On the other hand Cyp19-Cre is a transgenic strain in which the 
aromatase promoter drives Cre expression in granulosa cells during antral stages of 
follicle development (Habenicht and Aitken, 2010). 
 
1.1.2.1 Steroidogenesis 
One of the major roles of granulosa cells is the production of sex steroid hormones. 
Estrogens have a crucial role in controlling fertility and infertility in mammals. Sex 
steroids play important roles in the development of the ovulatory follicles, the generation 
of the preovulatory surge of gonadotropins, facilitating sperm transport by changing the 
consistency of cervical mucus, and preparing the endometrial layer of the uterus for 
implantation. Compared to cumulus cells, mural granulosa cells are more 
steroidogenically active, as indicated by higher levels of mRNA expression for 
steroidogenic enzymes including 17β-hydroxysteroid dehydrogenase (HSD17B1) and 
aromatase (CYP19A1). The abundance of Cyp19a1 mRNA in ovarian granulosa cells is 
regulated by factors which stimulate adenylyl cyclase and increase cAMP.  
In the ovary, FSH can lead to the activation of second-messenger signaling 
including cAMP, which drives the expression of CYP19A1 and HSD17B1 and thereby 
permits MGCs to produce estradiol by converting androgen which comes from the theca 
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cells (Figure 3) (Simpson et al., 2002). The two-cell, two-gonadotropin model describes 
the role of theca and granulosa cells in the production of steroids, highlighting the 
cooperation between the two cell types, which is necessary for estrogen production (Li et 
al., 2000). Other than sex steroids, granulosa cells are capable of producing growth factors 
including inhibin, activin, bone morphogenetic proteins 2 (BMP-2) and BMP-6. These 
molecules can communicate between the GCs and the oocyte and theca cells during their 
development. In addition, after ovulation the luteinized granulosa cells produce 
progesterone (Gilchrist et al., 2004, Pangas, 2012). 
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Theca cell 
Figure 3. Steroidogenesis in mural granulosa cells. 
In the growing follicle, androstenedione and testosterone can diffuse through the 
basement membrane. These androgens are then further transformed into estradiol in 
granulosa cells. Dotted arrows represent molecule translocations and plain arrows 
indicate an enzymatic conversion. Reproduced from reference (Lapointe and 
Boerboom, 2011). 
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1.1.2.2 Cumulus expansion 
In most mammals, the LH surge starts an ovulatory cascade by inducing cAMP 
signaling, which stimulates the expansion of the cumulus cells surrounding the oocytes, 
the rupture of the follicle wall, and the release of the fertilizable ovum. As mentioned 
above, one of the distinct differences between MGC and CC is the capacity of cumulus 
cells to undergo mucification and expansion. CCs secrete proteins creating a large round 
mass of expanded cumulus cells via an extensive rearrangement of the actin cytoskeleton 
and induction of hyaluronan synthesis, which transforms the tightly packed cumulus 
complex into a much larger volume of mucified cells. Hyaluronan is formed by various 
hyaluronan binding proteins including versican, inter-α trypsin inhibitor (IαI) and tumor 
necrosis factor stimulated gene 6 (TSG-6). This structure has viscoelastic properties which 
allow COCs to deform and easily pass through the ruptured follicle wall during ovulation 
(Nagyova, 2012). In vitro, cumulus expansion is induced by treatment with FSH, which 
stimulates cAMP signaling to produce a massive mucoid extracellular matrix. COCs 
expansion varies in different species, for instance mouse COC expansion in culture 
requires an oocyte secreted factor(s), termed the cumulus expansion enabling factor 
(CEEF). In comparison, FSH can induce rat, cow, and pig COC expansion in the absence 
of the oocyte (Gilchrist et al., 2004, Li et al., 2000).  
Small molecules such as ions, metabolites and amino acids can be transferred via 
gap junctions between the oocyte and cumulus cells as well as between cumulus cells to 
help oocyte growth and development (Gilchrist et al., 2004). 
 
 
 
 
 
15 
 
1.1.3 Theca cells 
Theca cells are vital components of the follicle, providing both structural support 
and the production of ovarian androgens for the growing follicle as it progresses through 
the developmental stages to produce a mature and fertilizable oocyte. Androgens are 
essential substrates for estradiol production in the neighbouring granulosa cells. Theca 
cells are recruited by factors secreted in activated primary follicles from surrounding 
stromal tissue (Magoffin, 2005). Theca cells are first observed follicles with two or more 
layers of granulosa cells. Before this stage, undifferentiated theca cells do not express LH 
receptors or steoidogenic enzymes. As theca cells are only associated with growing 
follicles, it is assumed that the follicle itself produces factors that signal to the stroma to 
recruit cells that form the theca. Theca cells have some necessary roles during 
folliculogenesis, such as the synthesis of androgens and provide crosstalk with the oocyte 
and granulosa cells during follicle development. Moreover, they play an important role in 
the establishment of a vascular system that creates communication with the pituitary gland 
throughout the reproductive cycle, and delivers essential nutrients to these highly active 
cells. During atresia, the theca cells are often the last cell type to undergo apoptosis, and 
after ovulation, theca cells luteinize and form cells of the corpus luteum (Magoffin, 2005, 
Young and McNeilly, 2010). 
 
1.1.3.1 Steroidogenesis 
Theca cells are capable of producing androgen from circulating cholesterol (high 
and low-density lipoproteins) in response to LH from the pituitary gland, which activates 
cAMP signaling via a G protein-coupled receptor. Pulsatile release of LH triggers an 
increase in androstenedione and estradiol secretion by the ovary in many species. 
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Androgens synthesized in theca cells are transported to the granulosa cells where 
cytochrome P450 aromatase enzyme converts these androgens to estrone and 17β-
estradiol (Young and McNeilly, 2010). In theca cells, LH/cAMP induces the expression of 
the key steroidogenic enzymes cytochrome P450 cholesterol side-chain cleavage 
(CYP11A1), cytochrome P450 17β-hydroxylase/C17–20 lyase (CYP17A1), 3β-
hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (HSD3B2) and steroidogenic acute 
regulatory protein (STAR). Cholesterol inside the theca cells is transported by sterol 
carrier protein 2 (SCP2) to the mitochondria. This internalization of cholesterol by the 
mitochondria is the rate-limiting step for steroidogenesis. STAR helps cholesterol to enter 
the inner mitochondrial membrane, where CYP11A1 converts it to pregnenolone. 
Pregnenolone can then be converted to progesterone by the enzyme 3β-hydroxysteroid 
dehydrogenase, or to 17α-hydroxypregnenolone by the enzyme CYP17A1 (Figure 4) 
(Conley and Bird, 1997, Lapointe and Boerboom, 2011). 
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 Granulosa
Figure  4. Enzymatic control of steroidogenesis in the theca cell. 
LH can stimulate theca cells to convert cholesterol into androstenedione and 
testosterone, which can diffuse to the granulosa cell layer. Dashed arrows represent 
molecule translocations and plain arrows indicate an enzymatic conversion. Reproduced 
from reference (Lapointe and Boerboom, 2011). 
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1.1.4 Basement membrane 
The basement membrane or lamina propria separates the theca and granulosa cell 
layers. The basal lamina creates a blood–follicle barrier between the two follicular cell 
compartments, and the presence of this extracellular matrix (ECM) boundary influences 
the interactions of follicular somatic cells. Some evidence supports the involvement of 
ECM components in regulating granulosa cell survival, proliferation, and steroidogenesis 
in the ovarian follicles of several species. A continuous remodelling of the basal lamina 
occurs during follicle development and its composition is changed during this process 
(Allegrucci et al., 2003). For instance, the laminin β1 chain was only detectable in the 
basal lamina of large preantral follicles, and type IV collagens α1 and -6 were reduced 
considerably in larger antral follicles (Rodgers et al., 2000).  
 
1.2 Endocrine regulation of follicle growth and development  
Folliculogenesis describes the progression of a number of small primordial 
follicles into large preovulatory follicles with the potential to either ovulate or undergo 
atresia. Regulation of follicle development is a complicated process that is controlled by 
several factors such as hormones, protein growth factors, and nutrition. Folliculogenesis 
can be coordinated by these factors via autocrine (affecting the cell type that produces the 
factor), paracrine (affecting cells adjacent to the one(s) producing the factor) and 
endocrine (affecting distant cells/organs) mechanisms (Armstrong and Webb, 1997, Webb 
et al., 2004). 
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1.2.1 Gonadotropins 
LH and FSH are called gonadotropins because stimulate the gonads, the testes in 
males, and the ovaries in females. They are both are essential for steroidogenesis, 
spermatogenesis, folliculogenesis, and ovulation. They are non-covalently linked 
heterodimeric glycoproteins include a common α-subunit and specific β subunits. Distinct 
genes encode the gonadotropin subunits, which are synthesized as precursor proteins and 
processed and secreted by the pituitary gonadotropes of the anterior pituitary (Burger et 
al., 2004). Pituitary gonadotropins release is under the acute trophic control of the main 
reproductive system regulator; the hypothalamic decapeptide gonadotropin-releasing 
hormone (GnRH). GnRH is released and transported to the anterior pituitary in a pulsatile 
manner, where it binds to specific receptors and regulates gonadotropin biosynthesis and 
secretion. The pulse is modulated by a wide variety stimulatory and inhibitory feedback to 
the both hypothalamus and the pituitary.  
Steroidal hormones can regulate gonadotropin levels by adjusting the GnRH pulse 
frequency at the levels of the in hypothalamus, and by acting directly on the pituitary 
gonadotrope cells. On the other hand, the members of the transforming growth factor-β 
superfamily, activin and inhibin, act at the level of the pituitary to control FSH secretion 
(Figure 5). Both LH and FSH exert their effects on ovarian somatic cells via G protein-
coupled receptors that activate several signaling pathways (Burger et al., 2004, Dohler et 
al., 1977).  
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1.2.1.1 FSH 
It is now well accepted that circulating FSH concentrations increase transiently 
with the emergence of each follicular wave during estrous. FSHR (FSH receptor) mRNA 
is detected in follicles with only one or two layers of granulosa cells in humans (Oktay et 
al., 1997).  
Suppression of FSH secretion inhibits follicular waves in cattle (Turzillo and 
Fortune, 1990). One study in cattle shown that a single follicle continues to grow and 
Figure 5. Regulation of gonadotropins 
FSH and LH plasma concentrations above threshold levels lead to the emergence of 
greater inhibitory feedback, and thus a reduction in gonadotropin secretion. Estradiol 
increases GnRH pulse frequency through a positive feedback mechanism, and results 
in elevated LH secretion. However, progesterone has a negative feedback effect on 
pulse frequency; therefore LH secretion is suppressed in the presence of a functional 
corpus luteum. Moreover, activin, opposite to inhibin, can stimulate FSH release.  
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mature because it acquires increased sensitivity to FSH, while further development of 
other follicles in the same cohort with less sensitivity to FSH is inhibited. Follicles, 
growing under the FSH support, start producing more estradiol and inhibin, which act on 
the anterior pituitary to inhibit FSH secretion through a negative feedback mechanism. 
The decline in FSH concentrations is closely related with the selection of one follicle as 
dominant and others as its subordinates (Gibbons et al., 1997). Generally, FSH is 
responsible for oocyte maturation indirectly by inducing Lhcgr in GC and estrogen 
synthesis. In absence of FSH, follicle development fails and ovulation does not occur. 
FSH acts through G-protein couple receptors to transduce its signal. Binding of FSH to its 
receptor results in cAMP synthesis as a second messenger, resulting in stimulation of PKA 
and the p38 mitogen-activated protein kinase (MAPK) signaling pathway (Levallet et al., 
1999). 
 
1.2.1.2 LH 
LH acts via G protein coupled receptors in the preovulatory follicle. LH receptors 
are first expressed on the cells of the theca interna at the tertiary stage of follicle 
development, and this expression is maintained until the preovulatory stage. In addition, 
granulosa cells of large estrogenic antral follicles develop LH receptors, as do luteal cells. 
(Ashkenazi et al., 2005). LH controls granulosa cell differentiation, cumulus expansion 
and progesterone production. Meiosis in the oocyte, arrested in the first meiotic division 
during embryogenesis, resumes following the luteinizing hormone surge. LH also up-
regulates the expression of proteases that allow the follicle wall to rupture and release the 
oocyte. Luteinizing hormone increases steroidogenesis by promoting cholesterol transport 
to mitochondria and the stimulation of the expression of steroidogenic genes.  
 
 
22 
 
The LH surge induces a large increase in mRNA encoding epiregulin (EREG) and 
amphiregulin (AREG), which then activate the EGFR (epidermal growth factor receptor) 
and initiate the ovulatory cascade and induce oocyte maturation (Hsieh and Conti, 2005). 
The LH surge also results in increased synthesis of prostaglandins in the preovulatory 
follicle that are required for ovulation (Richards, 1994). 
 
1.2.2 Estradiol and progesterone  
Estradiol and progesterone biosynthesis within the ovary is critical for various 
physiological processes related to normal growth, development, and reproduction (follicle 
development, regulation of gonadotropin secretion for ovulation and maintenance of 
pregnancy) (Stormshak and Bishop, 2008). 
FSH stimulates the production of estrogens by the granulosa cells of the ovarian 
follicles. Healthy ruminant follicles contain higher estradiol and lower progesterone 
concentrations than atretic follicles. It is well established that small follicles contain 
relatively little estradiol in their follicular fluid, and estradiol concentrations increase with 
follicle size in healthy growing follicles while decreasing in subordinate follicles. In cattle, 
once the dominant follicle reaches its maximum diameter, estradiol concentrations 
dramatically increase in follicular fluid and it decreases when follicle starts regressing. 
Thus, estradiol concentrations are a key biochemical indicator of health and atresia of 
ruminant follicles (Price et al., 1995). 
Progesterone has a critical role in the regulation of ovulation. The physiological 
effects of progesterone are mediated by two nuclear receptors (PR-A and PR-B). Studies 
of progesterone receptor-null (Pr-KO) mice showed that PRs are required for LH-
dependent follicle rupture (Conneely, 2010). 
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In general, the action of progesterone on the reproductive tract is to stimulate the 
proliferation of uterine stromal cells, the epithelial cells of the mammary gland, and to 
ensure the maintenance of pregnancy. Progesterone, in addition to estradiol, plays an 
important role in the regulation of LH secretion by exerting negative feedback on the 
hypothalamus-pituitary axis, thereby reducing the release of GnRH and LH (Murphy, 
2000, Niswender et al., 2000). 
 
1.2.3 Androstenedione and testosterone  
Androstenedione is a 19 carbon steroid hormone produced in the adrenal glands 
and the gonads as an intermediate product that can be converted to testosterone or 
estradiol. Testosterone is the primary mammalian androgen. It is the mainly known as a 
male sex hormone and an anabolic steroid. Testosterone is primarily secreted in the 
testicles of males and the ovaries of females, although small amounts are also secreted by 
the adrenal glands. In theca cells, much cytochrome P450 17α-hydroxylase enzymatic 
activity is present, and so pregnenolone (the first steroid in the steroidogenesis pathway) is 
converted to 17α-hydroxypregnenolone. This 17α-hydroxypregnenolone is then converted 
to androstenedione by P450 17α- hydroxylase (CYP17 or P45017-OH) and 3β-
hydroxysteroid dehydrogenase (3β-HSD or HSD3B2). Ruminant theca cells convert 
limited amounts of androstenedione to testosterone with the enzyme 17β-hydroxysteroid 
dehydrogenase, and both androstenedione and testosterone can then diffuse to 
neighbouring granulosa cells for further conversion to estrogens (Gibbons et al., 1997). 
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1.2.4 Intraovarian regulators 
Ovarian folliculogenesis is a dynamic process controlled by gonadotropins. 
However, intraovarian regulators also play key roles in granulosa cell biology, maturation 
of the oocyte, and neovascularization. These factors can act in an autocrine or paracrine 
manner through specific cell membrane receptors. The early stages of follicular growth are 
gonadotropin-independent, and these stages may therefore be controlled by intraovarian 
signaling (Ben-Ami et al., 2006). 
 
1.2.4.1 IGF 
The IGF family members are polypeptides similar to insulin. The IGF system 
includes two ligands (IGF-I and -II), 6 IGF binding protein (IGFBPs) and two receptors 
(IGF1R and -2R). 
IGFs are regulated by gonadotropins and growth factors such as growth hormone 
(GH) and oxytocin in ovarian follicles, corpora lutea, and oocytes. In ruminants and 
rodents, IGF-I plays a key role in reproduction, whereas in human IGF-II appears more 
important. Whereas IGF-I probably has no effects on primordial follicles, IGF-I and IGF-
II stimulate the growth of secondary follicles in vivo and in vitro. In antral follicles, IGF-I 
stimulates granulosa cell proliferation and synergizes with gonadotropins to promote 
differentiation of follicle cells and inhibit apoptosis (Beg and Ginther, 2006). IGFs 
increase the expression of FSH and LH receptors and the response of granulosa cells, 
theca cells, and oocytes to gonadotropins. Moreover, IGFs are considered to be one of the 
main local mediators of many hormones, including gonadotropins and GH (Quirk et al., 
2004).  
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IGF-I and IGF-II are produced in large amounts in the corpus luteum to support 
luteal cell development and function (Beg and Ginther, 2006). Both IGF-I and IGF-II in 
mice promoted nuclear maturation of oocytes, with stimulation of proliferation and 
inhibition of apoptosis in the surrounding cumulus oophorus, resulting in increased 
developmental capacity of the oocytes and blastocyst production after in vitro fertilization 
(IVF) (Demeestere et al., 2004).  
In addition, it is possible that IGF-I and IGF-II mediate effects of nutrients and 
nutrition-dependent metabolic hormones on reproductive processes (Sirotkin, 2010, Webb 
et al., 2004). IGF1 seems to stimulate estradiol and progesterone secretion and can 
stimulate PI3K (phosphoinositide 3-kinase) and PKC (protein kinase C) to increase the 
expression of CYP19A1 and other steroidogenic enzymes in bovine granulosa cells, and 
regulate secretion of progesterone and androstenedione in theca cells (Silva and Price, 
2002, Stocco, 2008b). 
The IGFBPs consist of a family of six non-glycosylated peptides with relatively 
low molecular weights, which serve to regulate the bioavailability of IGFs within the 
follicle. IGFBP2, 4 and 5 serve as IGF carriers in the serum, thereby extending their half-
lives by preventing their degradation. IGFBPs also regulate the effects of IGFs by 
preventing their access to cell membrane surface receptors (Ben-Ami et al., 2006). 
 
1.2.4.2 TGF-β superfamily 
The TGF-β superfamily of extracellular signaling molecules includes over 35 
structurally related but functionally diverse proteins. These proteins are widely distributed 
throughout the body and acts as extracellular ligands involved in numerous physiological 
processes during both prenatal and postnatal life. This big superfamily has been divided 
 
 
26 
 
into several subfamilies which include the TGF-β (including TGF-β1, TGF-β2 and TGF-
β3), bone morphogenetic protein (BMP, with 20 members), growth and differentiation 
factor (GDF) (at least nine members), activin/inhibin (including activins A, AB and B and 
inhibins A and B), and glial cell-derived neurotrophic factor (GDNF) (including GDNF, 
artemin and neuturin) subfamilies, as well as other members including anti-Mullerian 
hormone (AMH) and nodal (Knight and Glister, 2006). Several members of this 
superfamily are expressed by oocytes, granulosa cells and theca cells, and have been 
implicated in granulosa and theca cell proliferation, atresia, steroidogenesis, oocyte 
maturation, ovulation and luteinization (Knight and Glister, 2003).  
The TGF-β superfamily members GDF-9 and BMP-15 are expressed in the oocyte 
from an early stage of development, and play key roles in promoting follicle growth to the 
primary stage. Studies on later stages of follicle development have indicated important 
roles for activin, BMP-2, 5 and 6, theca cell-derived BMP-2, 4 and 7 and oocyte-derived 
BMP-6 in promoting granulosa cell proliferation, follicle survival and the prevention of 
premature luteinization and/or atresia (Figure 6). TGF-β increases LH receptor production 
in granulosa cells in response to FSH stimulation, whereas it inhibits androgen production 
in theca cells. In monovular species, dominant follicle selection may depend on the 
sensitivity of the growing cohort of small antral follicles to FSH. Changes in the 
intrafollicular concentrations of molecules including activins, AMH, GDF-9 and several 
BMPs may contribute to this selection process by controlling both FSH- and IGF-
dependent signaling pathways in granulosa cells (Knight and Glister, 2003, 2006). Activin 
may also play a positive role in oocyte maturation and competency, and can increase FSH 
receptor expression in granulosa cells during the preantral to antral transition. Follicles 
with greater capacity for activin signaling are more sensitive to FSH, and show better 
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progression to the antral stage (Findlay et al., 2001). One study suggested that inhibin 
production by large antral follicles is a mechanism for the selection of the dominant 
follicle and the induction of apoptosis in small subordinate follicles (Vitale et al., 2002).  
 
  
 
 
 
 
 
 
 
 
1.2.4.3 FGFs 
The fibroblast growth factor (FGF) superfamily is one of the largest families of 
growth factors that have been implicated in follicle cell function. There are 22 known 
Figure  6. TGF-β superfamily members and their receptors and binding 
proteins are expressed in different follicle cells. 
TGF-β superfamily members including GDF-9, inhibins, activins, TGF-β, BMPs 2, 
4, 5, 6 and -7 and AMH are expressed in theca cells, granulosa cells and oocytes.  
These molecules serve as as intrafollicular autocrine (white arrows) and paracrine 
(black arrows) signaling molecules. Reproduced from reference (Knight and Glister, 
2006). 
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FGFs classed into 7 subfamilies. Most of the members of this family act through single-
pass transmembrane tyrosine kinase receptors (FGFR) which are encoded by four separate 
genes and give rise to four distinct receptor proteins, FGFR1–4 (Schams et al., 2009). 
Fibroblast growth factors are most famous for their critical roles in organogenesis in the 
developing embryo (Schams et al., 2009). In the ovary, FGFs are predominantly expressed 
in oocytes and/or theca cells but are absent from the granulosa layer. FGFs are well known 
to stimulate granulosa cell proliferation. A consequence of increased proliferation is a 
decrease in differentiation and estradiol secretion (Buratini et al., 2007). In the 
reproductive system, FGF2, FGF9, FGF7, and FGF18 play roles in gonadal development 
and sex differentiation (Portela et al., 2010, Schams et al., 2009). Moreover, FGF7 and 
FGF10, which belong to the same FGF subfamily, are expressed predominantly in theca 
cells, and their main receptor (FGFR2) is located on granulosa cells. FGFs are therefore 
important for paracrine signaling in the ovarian follicle (Portela et al., 2010). FGF2 is one 
of the members of this family that can regulate angiogenesis in the theca. FGF2 also acts 
on granulosa cells to promote granulosa cell proliferation, inhibit apoptosis, and decrease 
steroidogenesis (Jiang et al., 2011). FGF9 is also expressed predominantly in theca cells 
and stimulates progesterone secretion by granulosa cells. FGF8 cooperates with BMP15 to 
stimulate glycolysis in cumulus cells (Portela et al., 2010). 
FGFs can activate different interacellular pathways including 1) MAPK, widely 
accepted to be responsible for the mitogenic responses of cells to FGFs, 2) phospholipase 
C (PLC), which activates PKC and calcium signaling by catalysing the production of 
diacylglycerol and inositol-1,4,5-triphosphate, and 3) PI3K and AKT (Jiang et al., 2011). 
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 1.2.4.4 EGF 
Epidermal growth factor (EGF) is a protein with 53 amino acid residues and three 
intramolecular disulfide bonds, and plays crucial roles in reproduction. Members of the 
EGF-like family have highly similar structural and functional characteristics. Aside from 
EGF, other family members include TGF-α, amphiregulin, epiregulin, betacellulin (BTC), 
epigen, neuregulins and heparin-binding EGF-like growth factor. These proteins can work 
through four types of transmembrane receptors (Ashkenazi et al., 2005, Ben-Ami et al., 
2006). 
Because cumulus and oocyte cells do not have LH receptors, it has been proposed 
that factors released by mural granulosa cells function in an autocrine and paracrine 
manner to transduce the effects of LH within the follicle. Intrafollicular release of 
members of the EGF-like family may fulfil this role (Park et al., 2004). It is now known 
that the EGF-like growth factors AREG, EREG and BTC, rather than EGF, are rapidly 
and transiently induced in the somatic cells of the preovulatory follicle by LH (Ashkenazi 
et al., 2005, Hsieh and Conti, 2005, Park et al., 2004). LH/hCG induction of these EGF-
like growth factors has been reported in multiple species (Chen et al., 2008, Fru et al., 
2007, Hsieh et al., 2007, Wang et al., 2007). 
The up-regulation of EGF ligands was initially proposed to occur selectively in 
mural granulosa cells, from which the ligands would be shed by members of the matrix 
metalloprotease (MMP) or a disintegrin and metalloprotease (ADAM) families to enable 
paracrine signaling to the cumulus layer (Conti et al., 2006). The mature growth factors 
bind to members of the EGFR (also called ERBB1) family, leading to receptor 
dimerization and autophosphorylation, and activation of downstream signaling cascades 
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including the ERK1/2, AKT, MAPK (via Gγ-c-Src) and PKC pathways to elicit distinct 
biological effects (Conti et al., 2012).  
 
1.3 Folliculogenesis and the ovarian cycle 
The major role of the ovary is the production of mature oocytes for fertilization. 
Folliculogenesis, the growth and development of ovarian follicles from primordial to 
preovulatory, is a prolonged process dependent on interactions between the oocyte and the 
somatic cells including the granulosa and theca cells. The ovarian reserve is determined by 
the number of primordial follicles in the ovary. Primordial follicles are activated for 
growth and pass through stages of development until they reach the antral stage. A group 
of antral follicles is then recruited for further growth, which is followed by the selection of 
a dominant follicle in monovular species. These processes are under the control of 
endocrine as well as paracrine factors in the ovary (Fortune et al., 2004, McGee and 
Hsueh, 2000). In response to preovulatory LH surges during each reproductive cycle, the 
dominant follicle ovulates and releases the mature oocyte for fertilization, while the 
remaining theca and granulosa cells will be transformed into corpus luteum through 
luteinization (Figure 7) (McGee and Hsueh, 2000). 
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1.3.1 Primordial germ cells 
The mammalian germ cell lineage is established early during development. 
Primordial germ cells (PGCs) originate in the proximal region of the epiblast, close to the 
extra embryonic endoderm, which during gastrulation clusters through the posterior part 
of the primitive line to become PGCs. These cells move into the endoderm of the yolk sac, 
Figure 7. Schematic diagram of the ovary 
The ovary is a dynamic organ that undergoes dramatic changes in structure and 
function. The follicle is the major endocrine and reproductive compartment of the 
ovary, and undergoes growth, rupture and formation of the corpus luteum during its 
life span. Taken from (McDonald and Pineda, 1989).  
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then proliferate and migrate via the yolk sac and hindgut endoderm at the caudal end of 
the embryo, and finally via the dorsal mesentery of hindgut to the genital ridges at the 
ventral sides of the mesonephros (Barnett et al., 2006). Active oogonia can recruit somatic 
pregranulosa cells from the surface epithelium at this stage. The oogonia then attach to 
pregranulosa cells and enter meiosis, during which at least 80% of the germ cells, but not 
their pregranulosa cells, undergo apoptosis (Scaramuzzi et al., 2011).  
Primordial germ cells differentiate under the influence of signals from members of 
the transforming growth factor β superfamily, including BMP2, BMP4, and BMP8B. 
BMP2 originates from the endoderm, whereas BMP4 and -8b are from the extra-
embryonic ectoderm. Loss of any of these signals prevents the formation of most or all of 
the primordial germ cells. (Barnett et al., 2006, Ying and Zhao, 2001). Conditional 
knockout mice have helped to identify genes required for primordial germ cell 
proliferation and migration. The c-kit receptor tyrosine kinase and its ligand (kit ligand, or 
stem cell factor) are required for primordial germ cell survival and migration. Expression 
of integrin β1 on the primordial germ cell surface is also required for successful migration 
to the genital ridge (Barnett et al., 2006).  
 
1.3.2 Transition from oogonia to oocyte 
PGCs are called oogonia once they reach to the gonads. Oogonia are connected to 
each other via intercellular cytoplasmic bridges. These oogonia are surrounded by 
mesonephros somatic cells, forming germ cell clusters or nests. These germ cell clusters 
break down before or after birth (according to species) to allow the formation of 
primordial follicles (Figure 8). Improper germ cell cluster breakdown may cause 
polyovular follicles (follicles with more than one oocyte).  
 
 
33 
 
Oogonia have higher mitotic activity compare to PGCs and undergo several 
divisions before starting meiosis. This mitotic activity is the major determinant of the size 
of the oocyte pool. On the other hand, a huge number of oogonia undergo atresia at this 
stage (approximately 60% in sows, 80% in rodents, 90% in humans and even more in 
sheep and cows (van den Hurk and Zhao, 2005). The end of reproductive life occurs when 
the follicle reserve is expended through follicle development and atresia. (Oktem and 
Urman, 2010). 
Several genes are known to play roles in primordial follicle formation, including 
Dazla (deleted in azoospermia), which is essential for the differentiation of germ cells, and 
Figla (factor in the germline alpha), which is essential for follicle formation and the 
interaction between the oocyte and granulosa cells. Nerve growth factor (Ngf) is involved 
in primordial follicle assembly (Barnett et al., 2006).  
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1.3.3 Formation of primordial follicles 
In term of morphology, primordial follicles in most species consist of small 
diplotene oocytes with a zona pellucida layer, surrounded by a flat layer of granulosa cells 
(Figure 9) (Rodgers and Irving-Rodgers, 2010). In primordial follicles, the granulosa cells 
and oocyte have receptors for some growth factors but not for gonadotropins. However, at 
this stage they do not require FSH and LH for their survival and development (Fortune et 
al., 2011). Around the initiation of follicle formation, estrogen levels are decreased 
Figure 8. Germ cell cluster breakdown and formation of primordial follicles. 
Germ cells are present in the ovary during embryogenesis. Around birth, germ cell 
clusters start to break down and form primordial follicles. Several mechanisms 
including apoptosis are involved in this process. Taken from (Barnett et al., 2006). 
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relative to the period of germ cells clusters, and low amounts of androgens and progestins 
are detectable. Steroid production could be important for primordial follicle formation, 
and seems to be independent of gonadotropin secretion (van den Hurk and Zhao, 2005). 
A large number of factors including transcription factors, zona proteins, meiosis-
specific enzymes and nerve growth factors are important for primordial follicle assembly 
(Oktem and Urman, 2010). Studies have identified a variety of genes involved in the 
formation of primordial follicles, which include sporulation protein homology (Spo11), 
disrupted meiotic cDNA 1 homologue (Dmc1) and muts homologue 5 (Msh5). All three 
genes are necessary for the initiation of double strand DNA breaks during meiosis and are 
involved in recombination (Barnett et al., 2006).  
 
1.3.4 Transition of primordial follicles to primary follicles  
Primary follicles are similar to primordial follicles in terms of size, but have more 
cubical-shaped granulosa cells. Primordial follicles first develop into primary follicles 
prior to or after birth (according to species), and this process continues postnatally until 
the ovarian reserve is depleted, which takes more than a year in rodents and several 
decades in women (Oktem and Oktay, 2008). 
The transition of a primordial follicle into a primary follicle is more of a slow 
maturation than a growing process, as the diameter of its oocyte hardly changes (Rodgers 
and Irving-Rodgers, 2010). Communication among the oocytes, granulosa and certain 
extra cellular matrix components and autocrine/paracrine growth factors play important 
roles in this transition and subsequent growth of follicles (Oktem and Urman, 2010).  
Inhibitory and stimulatory factors from different cells (oocytes, somatic cells, and 
stroma) control primary follicle development. Recently, it has been found that inhibitory 
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signals keep primordial follicles in the dormant state. For example, loss of function of 
some inhibitory molecules for follicular activation, including the tumor suppressor 
tuberous sclerosis complex 1 (Tsc-1), phosphatase and tensin homolog deleted on 
chromosome 10 (Pten), Forkhead box O3 (Foxo3a), newborn ovary homeobox protein 
(Nobox) and forkhead box protein L2 (Foxl2), leads to premature activation of the 
primordial follicle pool (van den Hurk and Zhao, 2005).  
According to studies on transgenic animal models and on the human ovary, several 
members of the TGF-β super family, such as AMH, activins, BMP-4, BMP-7, and GDF-9, 
play critical roles in the regulation of primary follicle activation. There are other growth 
factors and cytokines that act at a paracrine level in the formation of primary follicles, 
such as kit-ligand, fibroblast growth factor-7 and the leukemia inhibitory factor, which 
have been shown in vitro to promote follicle growth from the primordial to the primary 
stage, stimulate oocyte growth and the proliferation of theca cells (Barnett et al., 2006, 
Oktem and Oktay, 2008). 
 
1.3.5 Follicle growth to pre-antral and antral stages 
A follicle with two or more layers of granulosa cells is deemed a secondary or 
preantral follicle. At this stage, the oocyte enters its growth phase, its diameter increases, 
granulosa cells become more proliferative, and a theca layer develops around the 
granulosa cells. Moreover, at this stage the zona pellucida completely forms, providing a 
protective coat around the oocyte composed of three glycoproteins; ZP1, ZP2 and ZP3 
(figure 9) (Eppig, 2001).  
During oocyte growth, RNA and protein synthesis increases, and ribosomes, 
mitochondria and other organelles increase in number. Granulosa cells form gap junctions 
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with the oocyte to permit them to communicate, transfer nutrients, metabolic precursors 
(such as amino acids and nucleotides), informational molecules (neurotropins and growth 
factors) and inhibitory and stimulatory meiotic signals (van den Hurk and Zhao, 2005). At 
this stage the follicle begins to form a small antral cavity which fills with follicular fluid 
within the granulosa cell layers along with increased vascularization of the theca layer, 
continued growth of oocytes and proliferation of granulosa and theca cells (Oktem and 
Urman, 2010). 
Development of a multi-layered secondary follicle from a primary follicle with a 
single layer of granulosa cells is a slow process that does not appear to be stimulated by 
the gonadotropins. However, the number of developing secondary follicles, their size, and 
rate of atresia are influenced by gonadotropins. FSH is the predominant survival factor, 
and acts to stimulate gap junction formation in granulosa cells. In addition, LH stimulates  
the synthesis of androgen by theca cells. Although preantral follicles are able to respond to 
gonadotropin hormones, they can develop to the antral stage with minimal circulating FSH 
and without FSH receptors (van den Hurk and Zhao, 2005).  
Some locally produced members of the TGF-β super family including activins, 
BMP-4, BMP-7, TGF-β and BMP-15, play crucial roles in the growth of primary follicles 
into preantral follicles (Oktem and Urman, 2010). Other growth factors such as EGF, 
IGFs, FGF2 and FGF7 have been associated with the survival and development of 
secondary follicles in various rodent and domestic species. These growth factors suppress 
follicle cell apoptosis, while stimulating granulosa cell proliferation and differentiation 
under in vitro conditions. Also, AMH appears to have a negative effect on preantral 
follicle development beyond the primordial to primary transition (Oktem and Urman, 
2010). 
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Further progression of the developing preantral follicle to the antral stage is 
characterized by formation of a fluid-filled cavity (Figure 9). Antral fluid is a source of 
essential substances derived from blood and secretions of the follicular cells, notably 
including gonadotropins, steroids, growth factors, enzymes, proteoglycans, and 
lipoproteins. The signals for antrum formation are not well characterized. In vitro studies 
with rodent follicles showed there is a possible role for FSH, LH, activin, KL (kit-ligand) 
and EGF in antrum formation. FSH becomes a critical determinant of further follicle 
growth and survival at this stage. Members of the TGF-β family, such as oocyte-derived 
GDF9, BMP15, BMP6 and granulosa cell-derived activin not only promote granulosa cell 
proliferation, but also modulate FSH-dependent follicle function in this stage (Oktem and 
Oktay, 2008).  
Follicular development begins with the growth of a recruited cohort of small 
preantral follicles. From this pool, only a few follicles are selected to grow, while the 
remaining will undergo atresia. Follicular development from recruitment to maturity can 
occur during two or three follicular waves throughout one estrous cycle in the bovine 
species. These waves also occur before puberty and during pregnancy and resulting in 
depletion of primordial follicles.  
 
1.3.6 Selection process of the dominant follicle  
The selection process during a follicular wave is characterized by the continued 
growth of the developing dominant follicle and reduced growth of the subordinate 
follicles. The antral follicle selection process occurs as FSH levels decrease (with high 
pulsatile secretion of LH). Follicle selection in monovular species such as the human and 
the cow is the process whereby only one follicle is chosen from a wave of growing 
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follicles to continue to grow and ovulate. However, in polyovular species such as pigs and 
rats, multiple follicles are selected and grow synchronously until ovulation. During this 
phase, the follicles grow at a similar rate and each follicle has the capacity to becoming a 
dominant follicle (Fortune, 1994). An extensive network of endocrine, autocrine, and 
paracrine interactions between germ cells and somatic cells is required for a large antral 
follicle to reach preovulatory status. Gonadotropins and local factors produced by the 
antral follicle itself and by neighbouring small preantral follicles participate in the 
selection process (Oktem and Oktay, 2008). 
There are different theories about the mechanisms of follicular dominance. One 
theory is that in both rodents and cattle, the selected antral follicle shows increased FSHR 
expression and expresses LHR in granulosa cells, and therefore becomes more sensitive to 
FSH and LH-responsive. This allows the continued development of a selected antral 
follicle during a period when FSH levels drop in response to high estrogen and inhibin 
output by the selected follicle. A second theory suggests follicle dominance is established 
early by an increase in IGF1 within the chosen follicle. A third theory postulates that IGF1 
and FSH work synergistically to make the selected follicle grow faster and produce 
increased amounts of estradiol, consequently slowing down the growth of the other 
follicles (Lucy, 2007a). However, the exact mechanism of large follicle selection remains 
unclear. 
TGF family members play important roles in follicle selection. Activin-A and 
TGF-β increase FSH receptor expression and upregulate FSH-induced aromatase activity 
and LH receptor expression, while downregulating theca androgen production and 
preventing premature luteinization or atresia. BMP15 and GDF9 also modulate FSH 
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action and inhibit FSH stimulated progesterone production. In addition, GDF9 induces 
CYP19A1 activity and FSH induced LHR expression. (Oktem and Urman, 2010). 
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Figure  9. A summary of folliculogenesis in the ewe as an example for mono-
ovular species. 
The vertical axis of this diagram shows the growth of the follicle and oocyte and the 
number of granulosa cells, from primordial to ovulatory stages. The horizontal axis 
shows the morphological characteristics of follicles during growth and development 
and the presence of different layers and receptors. Taken from (Scaramuzzi et al., 
2011). 
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1.3.7 Atresia  
The fetal mammalian ovary contains millions of germ cells, which decrease in 
number by birth and decrease further postnatally with the onset of follicular development. 
Only limited numbers of primordial follicles are selected for ovulation while the rest of 
follicles undergo atresia (75–99.9%). It was found that atresia occurs in the ovary of all 
species (Wood and Van Der Kraak, 2001, Yu et al., 2004). Follicular atresia occurs by 
apoptosis, or programmed cell death, in both the somatic cells of the follicle and the 
oocyte. Apoptosis is an essential part of life for multicellular organisms, at a physiological 
level to eliminate unwanted cells in response to developmental signals or toxic 
stimulation, and it is tightly regulated and balanced against mitosis (Hengartner, 2000). 
Characteristic features of apoptosis include condensation of nuclear chromatin, 
increased complexity of the nuclear and cellular outlines, fragmentation and budding of 
the cell, the production of the membrane-bound apoptotic bodies and their phagocytosis 
by macrophages, cytoplasmic vacuolization, cell contraction, and rapid nuclear DNA 
cleavage (Hussein, 2005).  
Two general mechanisms activate apoptosis, one involves the binding of death 
molecules to cell surface receptors (death receptor pathway), and the other involves 
signals arising within the cell (mitochondrial pathway). Two important families of 
apoptosis regulators are the caspase family and the B-cell lymphoma 2 (BCL-2) family 
(Hengartner, 2000). Caspases include both ‘initiator’ caspases (8 and 9) and ‘effector’ 
caspases (3, 6 and 7). These proteases cleave enzymes and proteins essential to the cell’s 
viability. Caspases participate in the formation of the apoptosome holoenzyme, which is a 
multi-protein complex that notably includes cytochrome c, APAF-1 and pro-caspase 9. 
Within this complex, pro-caspase 9 undergoes autoactivation to promote cleavage of 
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caspase-3. Caspase-3 then cleaves its target substrates to effect the changes associated 
with apoptosis (Hussein, 2005).   
The BCL-2 family includes anti-apoptotic members, such as BCL-2 and BCL-XL, 
as well as proapoptotic members, including BAX, BID, BIK, BOD, BOK and BCL-XS. 
BCL-2 and BAX are expressed in granulosa cells of both fetal and adult ovaries, 
suggesting their possible role in atresia. The key function of BCL-2 family members is to 
regulate the release of pro apoptotic factors such as cytochrome c from the mitochondria 
into the cytosol. Expression of this gene family is related to gonadotropin levels, as higher 
levels of gonadotropins increase the expression of BCL-2 and decrease the expression of 
BAX (Hussein, 2005). 
Successful follicle development depends on the presence of gonadotropins and 
survival factors that promote follicle growth and protect cells from apoptosis (Quirk et al., 
2004). FSH and LH are important factors for the proliferation and survival of follicular 
somatic cells and the cyclic recruitment of antral follicles. Decreased levels of Fshr and 
Lhr mRNAs results in reduced granulosa cell response to gonadotropins, and consequently 
increased apoptosis in follicles. Elimination of serum gonadotropins after 
hypophysectomy leads to atresia and apoptosis of developing follicles (Tilly et al., 1992). 
IGF1 stimulates follicle survival, promotes proliferation, and inhibits apoptosis by 
stimulating the synthesis of estrogen, which is an apoptosis inhibitor (Billig et al., 1993). 
Paracrine factors produced by theca cells (including transforming growth factor α, 
keratinocyte growth factor and hepatocyte growth factor) bind to specific receptors 
expressed in granulosa cells and suppress apoptosis by endocrine factors. In the absence of 
survival factors, endogenous apoptosis pathways within the follicle become activated and 
lead to follicular atresia (Tilly, 1996).  
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1.3.8 Ovulation 
The dominant follicle shifts its gonadotropin dependence from FSH to LH during 
selection and is able to continue to grow while the subordinates regress. LH can activate a 
complicated signalling pathway to promote ovulation. LH receptors are present in theca 
and granulosa cells, but few or no receptors are found in cumulus cells or the oocyte 
(Russell and Robker, 2007). 
In preovulatory follicles, the LH surge stimulates pathways including the cAMP-
dependent serine kinase protein kinase A, extracellular regulated kinase (ERK1/2 or 
MAPK3/1), phosphoinositide 3-kinase/AKT (PI3K/AKT) and mitogen-activated protein 
kinase 14 (MAPK14 or P38) pathways (Conti et al., 2006, Panigone et al., 2008). LH 
rapidly induces the expression of ADAMs family members, which cleave and shed 
preformed EGF-like growth factors from the surface of mural granulosa cells. EGF-like 
growth factors (EREG, AREG and BTC) bind to EGF receptors on granulosa cells and 
induce the expression of genes related to cumulus expansion such as Has2, Ptgs2 and 
Tnfaip6 (Panigone et al., 2008, Park et al., 2004). EGF receptor signaling is mediated 
mostly by activation of the ERK1/2 pathway in granulosa cells as well as in cumulus cells. 
Prostaglandin (PGE) and the EGF-like factors produced by granulosa cells activate 
specific PGE and EGF receptors in cumulus cells and increase the expression of genes 
involved in making and stabilizing the hyaluronan matrix, as well as other genes related to 
immune responses including Cd34, Cd52, Alcam and Il6 (Shimada et al., 2006a, Shimada 
et al., 2006b). 
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1.3.9 Luteinization  
Luteinization is one of the main physiological events induced by the LH surge. It is the 
process whereby granulosa and theca cells stop proliferating and undergo terminal 
differentiation, leading to the formation and function of the corpus luteum (CL) (Stocco et 
al., 2007b). Cells undergoing luteinization begin expressing a new set of genes that 
allowing luteal cells to survive in a different hormonal environment. Biochemical changes 
in granulosa cells associated with luteinization include a significant increase in CYP11A1 
expression, the transient expression of progesterone receptors, as well as dramatic 
decreases in mRNAs encoding Cyp19a1 and Cyp17a1. These changes cause a transition 
from estrogen production in the preovulatory follicle to progesterone synthesis in the 
corpus luteum (Figure 10) (Richards et al., 1998). In the event of pregnancy, the corpus 
luteum becomes a metabolically highly active structure with a high progesterone 
production rate. Depends on the species if the oocyte is not fertilized, the CL regresses, 
allowing a new cycle to begin. Implantation, mating, or even cervical stimulation in some 
mammals initiates a complex mechanism resulting in the maintenance of CL function, 
ensuring a continuous supply of progesterone needed for fetal survival (Stocco et al., 
2007a). For example in a non-pregnant cow if there is no maternal recognition of 
pregnancy, PGF2α released from the endometrium which induces luteolysis, characterized 
by hypoxic cell death resulting from hyalinization of blood vessels (Ginther and Beg, 
2012). 
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Figure  10. Steroidogenesis in the corpus luteum. 
Luteal cells have the ability to transform cholesterol into pregnenolone and then 
progesterone. Taken from (Lapointe and Boerboom, 2011). 
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2. WNTs and WNT signaling  
2.1 WNT overview 
The WNT family is one of several important families of signaling molecules that 
have been identified over the past 20 to 30 years. The WNT genes encode a large family 
of secreted lipid-modified glycoproteins that have been identified in animals from hydra to 
humans. The WNT family plays crucial roles in the embryonic development of all animal 
species, and has also been implicated in adult tissue homeostasis. During development, 
WNTs have different roles in controlling cell fate, proliferation, migration, polarity, and 
apoptosis and are also implicated in a variety of human cancers (Cadigan and Liu, 2006, 
Logan and Nusse, 2004). 
The first WNT gene was identified in 1982 by Nusse and Varmus as an integration 
site for the Mouse Mammary Tumor Virus (MMTV). MMTV integration at this site 
activated a gene, originally named integration 1 (Int1), which encodes a secreted cysteine 
rich protein. In drosophila, the wingless (Wg) gene was identified as a recessive mutation 
affecting wing development. In 1987, researchers found that Wg was the homologue to 
mammalian Int1, due to a common evolutionary origin evidenced by similar amino acid 
sequences of their encoded proteins. The name WNT comes from a combination of Wg in 
drosophila and Int1 in mouse (Clevers, 2006, Wodarz and Nusse, 1998).  
 
2.2 WNT genes and proteins  
In humans and mice, 19 Wnt genes have been described. Human WNT genes are 
located very close to each other in the genome. Each WNT protein is characterized by an 
amino terminal signal for secretion, several sites for glycosylation, and a cysteine-rich 
segment (Miller, 2002).  
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WNT genes encode secreted glycoproteins of 350-400 amino acids (molecular 
weight from 39 kDa (WNT7a) to 46 kDa (WNT10a)). The majority of WNT proteins have 
around 35% similarity in amino acid sequence including a conserved pattern of 23-24 
cysteine residues, in addition to other conserved amino acids. This sequence identity 
increases (from 58% to 83%) among members of subgroups, such as WNT3 and WNT3a, 
which have overlapping sites of expression (Cadigan and Nusse, 1997, Miller, 2002). 
All WNT proteins are relatively hydrophobic molecules because of several post 
translational modifications including glycosylation, palmitoylation and palmitoleoylation 
that are essential for WNT secretion and function. For example, glycosylation is crucial 
for WNT protein folding, secretion and biological activities. These proteins have a 
conserved structure, which depends on the glycosylation and formation of several 
intramolecular disulfide bonds (Ching et al., 2008, Logan and Nusse, 2004, Miller, 2002).  
 
2.3 WNT receptors  
The frizzled (FZD) family of seven transmembrane-pass receptors (7TMR) are 
structurally similar to GPCR and are found exclusively at the plasma membrane of WNT 
responsive cells (Huang and Klein, 2004). In humans and mice, ten members of this 
family have been identified. Sequencing analysis suggests that the ten human frizzled 
genes can be divided into four groups: FZD1, FZD2 and FZD7 share approximately 75% 
amino acid identity, FZD5 and FZD8 share 70% identity, FZD4, FZD9 and FZD10 share 
65% identity, and FZD3 and FZD6 share 50% identity (Huang and Klein, 2004). The 
length of frizzled receptors varies from 500 - 700 amino acids. These receptors have three 
extracellular and three intracellular loops. Molecular characterization of FZDs showed the 
amino terminus is extracellular and contains a cysteine-rich domain (CRD) followed by a 
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hydrophilic region of 40-100 amino acids. The presence of the hydrophobic domains in 
the C terminal part of FZD receptors suggests that these receptors are related to the GPCR 
superfamily (Wodarz and Nusse, 1998).  
In addition to FZD proteins, the canonical WNT/β-catenin (CTNNB1) signaling 
pathway requires single-span transmembrane proteins that belong to a subfamily of low-
density lipoprotein (LDL) receptor-related proteins (LRPs). Mutations in Lrp6 in mice 
results in developmental defects similar to those seen in mice deficient for several 
individual WNT genes (Pinson et al., 2000). LRPs have relatively large extracellular and 
short cytosolic domains. Frizzled receptors activate β-catenin-dependent (canonical) as 
well as β-catenin-independent (non-canonical) pathways, whereas LRP5/6 function more 
specifically in the WNT/β-catenin pathway (He et al., 2004). Recent studies have 
identified other types of receptor molecules which can mediate non-canonical WNT 
signaling. One of them is the flamingo family of nonclassical cadherin molecules. 
Flamingos bind to frizzleds to form a protein complex that mediates non-canonical WNT 
signaling (Sugimura and Li, 2010). Moreover, receptor tyrosine kinase-like orphan 
receptor 1 and 2 (ROR1, 2), and a typical tyrosine kinase receptor (RYK), have been 
shown to act as WNT receptors (Kikuchi et al., 2009).  
 
2.4 WNT inhibitors  
WNT signaling is modulated by endogenous secreted substances, including two 
classes of antagonists: the members of the Dickkopf (DKK) and secreted FZD related 
protein (sFRP) families. Dickkopf proteins inhibit the canonical WNT signaling by 
binding to the LRP5/LRP6 component of the WNT receptor complex. Members of the 
sFRP family bind directly to WNTs or to the WNT receptor complex, therefore sFRPs can 
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inhibit both canonical and non-canonical pathways (Hsieh et al., 2002). In humans, the 
sFRP family consists of five members (sFRP1 to sFRP5) and orthologues of these genes 
have been found in all vertebrate species. WNT4 is one of the WNT family members that 
is regulated by both sFRP1 and 2 (Kawano and Kypta, 2003). 
The DKK family includes four members (DKK1, -2, -3 and -4) and a unique 
DKK3-related protein named Soggy (SGY). All these secreted proteins except SGY have 
two CRDs at their N terminus. DKK1, -2 and -4 have been reported to inhibit the 
WNT/CTNNB1 pathway whereas DKK3 does not show an affinity for LRP6 or an effect 
on WNT signaling (Figure 11B) (De, 2011, Kawano and Kypta, 2003). 
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2.5 Intracellular signal transduction  
WNTs interact with the CRD of FZDs, or with accessory proteins or coreceptors, 
to activate specific downstream signaling events and exert physiological effects. It is still 
not well known which WNT(s) bind to which FZD(s) (or co-receptor) to exert their 
Figure  11. Regulation of WNT signalling by physiological inhibitors. 
a) sFRPs prevent WNT from binding to its receptors or inhibit WNT signaling by 
binding to Frizzled. In this case, both the canonical and the noncanonical pathways 
are inactivated. b) DKK-1 interacts with LRP5/6, thereby preventing formation of the 
LRP5/6/WNT/Frizzled complex and consequently β-catenin stabilization. Axin 
brings together the proteins that promote β-catenin phosphorylation, enabling β-
catenin degradation and inhibition of the canonical pathway. The WNT/FZD complex 
can still activate non-canonical WNT signaling in presence of DKK. Reproduced 
from (Kawano and Kypta, 2003). 
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function. It is now believed that certain WNT proteins such as WNT5a and WNT11 have 
a tendency to activate non-canonical signaling, whereas other WNT proteins including 
WNT1 and WNT8 are known to preferentially activate canonical signaling (Cadigan and 
Liu, 2006).  
 
2.5.1 The canonical pathway 
Canonical WNT signaling controls the stability of the multifunctional protein β-
catenin. In the absence of WNT, a large multiprotein complex called the destruction 
complex is responsible of phosphorylation of β-catenin. This complex contains Axin, 
adenomatosis polyposis coli (APC) and glycogen synthase kinase 3β (GSK3β). β-catenin 
is phosphorylated by CK1 (casein kinase 1) at Ser45, followed by phosphorylation at 
Ser33, Ser37 and Thr41 by GSK3β. Phosphorylation results in the subsequent 
ubiquitination of the protein and its degradation by the cellular proteosomal machinery. In 
the resting state, the cytoplasmic β-catenin levels are thereby kept low (Rao and Kuhl, 
2010). 
The WNT/CTNNB1 pathway is activated by the binding of a WNT to a Frizzled 
family receptor and LDL receptor-related protein as a co-receptor (Cadigan and Liu, 
2006). In the presence of WNT ligands, a signal is tranduced via disheveled that disrupts 
the destruction complex. This event allows β-catenin to escape the complex in an 
unphosphorylated form and to translocate to the nucleus. In the nucleus, CTNNB1 
associates with various transcription factors that can modulate the transcriptional activity 
of different target genes (Figure 12A) (Boyer et al., 2010a). 
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2.5.2 The non-canonical pathways 
Some WNTs activate β-catenin independent pathways, also known as non-
canonical WNT pathways. The best-characterized non-canonical pathways are the 
WNT/Ca2+ and planar cell polarity (PCP) pathways (Kikuchi et al., 2009).   
Several reports have shown that WNT5a, WNT11 and WNT4 can stimulate the 
WNT/Ca2+ pathway. WNT-FZD signaling activation leads to release of intracellular Ca2+ 
through G proteins to activate phospholipase C, which in turn generates diacylglycerol 
(DAG) and inositol 1,4,5 triphosphate (IP3) and increases intracellular Ca2+ 
concentrations that can stimulate several Ca2+ sensitive proteins including 
calcium/calmodulin-dependent protein kinase II (CaMKII) and PKC. CaMKII has been 
shown to activate the transcription factor nuclear factor of activated T-cells (NFAT) via 
activation of calcineurin (CNA), as well as TGFβ activated kinase (TAK1) and Nemo-like 
kinase (NLK) which can antagonize CTNNB1/TCF signaling (De, 2011). It has been 
shown that activation of the WNT/Ca2+ pathway can inhibit the activation of the Wnt/β-
catenin pathway in Xenopus (Miller et al., 1999). 
The WNT/JNK pathway has a high level of overlap with the planar cell polarity 
pathway originally described in Drosophila (Rao and Kuhl, 2010). PCP signaling involves 
the activation of several small Rho GTPases, which have different intracellular targets 
(Miller, 2002). Following the binding of WNT to FZDs, DVL can active the small 
GTPase Rho via DAAM1 (DVL associated activator morphogenesis 1) (Kishida et al., 
2004). Another small GTPase of the Rho family that can be activated upon WNT/FZD 
binding and activation of DVL is RAC1. Activation of RAC1 stimulates the downstream 
effector c-Jun N-terminal kinase (JNK). JNK activation subsequently leads to the 
activation of transcription factors such as c-Jun (Figure 12) (Kikuchi et al., 2009). Studies 
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have shown that DAAM1 (dishevelled associated activator of morphogenesis 1), ROCK 
(rho-associated, coiled-coil-containing protein kinase 1) and JNK can act via different 
effectors mainly to modify the actin cytoskeleton, leading to cytoskeletal rearrangement 
and changes in cell morphology (Keller et al., 2003). 
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A B C
Figure  12. Multiple WNT signaling pathways. 
In the canonical pathway, when WNT acts on its cell-surface receptor consisting of 
FZD and LRP5/6, β-catenin escapes from the degradation complex of APC protein, 
AXIN and GSK3β, resulting in the accumulation of cytosolic β-catenin and its 
translocation to the nucleus, where it binds to TCF/LEF transcription factors and 
thereby stimulates the transcription of various genes. In the β-catenin-independent 
pathways, specific WNT and FZD proteins can act to increase intracellular Ca2+ 
concentrations, which in turn activates CAMKII and PKC, thereby activating 
transcription via factors such NFAT and up-regulating target gene expression. Some 
FZDs stimulate the PCP pathway, by which small GTPases (Rac and Rho) and JNK 
are activated.  JNK can phosphorylates c-JUN, which acts in conjunction with c-FOS 
to activate the transcription of target genes. Taken from (Laudes, 2011). 
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2.6 Role of WNT signaling in the ovary 
Ovarian follicular growth and the regulation of steroidogenesis are controlled by 
intraovarian growth factors. Members of the WNT family of signaling molecules have 
been shown to regulate ovarian cell function and follicular organization. WNTs attracted 
the attention of ovarian biologist when it was reported that inactivation of Wnt4 in mice 
results in partial female to male sex reversal and the loss of the majority of the oocyte 
reserve in the days prior to birth (Boyer et al., 2010a). Several WNTs and other 
components of WNT signaling pathways are expressed in the postnatal ovary and recently, 
studies using newer methods including transgenesis have helped to determine roles of 
some members of WNT pathway and its components (such as CTNNB1, WNT4 and 
FZD1, FZD4 and SFRP4) in folliculogenesis, steroidogenesis and female fertility (Boyer 
et al., 2010a).  
 
2.6.1 CTNNB1 
CTNNB1 has an essential role in cell adhesion and is a key signaling molecule in 
the canonical WNT pathway, which plays diverse and critical roles in embryonic 
development and in adulthood (Boyer et al., 2010a). CTNNB1, a transcriptional co-factor  
interacts with T-cell factor/lymphoid enhancer binding protein (TCF/LEF) to activate the 
transcription of target genes. In the absence of CTNNB1 signaling, TCF acts as a 
repressor for WNT target genes. When high levels of CTNNB1 are present in the nucleus, 
it converts TCF from a transcriptional repressor to an activator (Eastman and Grosschedl, 
1999). Recently, two important roles have been suggested for CTNNB1 in steroidogenesis 
and follicular growth, as detailed below.  
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2.6.1.1 Steroidogenesis 
As mentioned above, FSH induces estrogen biosynthesis by stimulating cAMP 
dependent signaling cascades to regulate transcription of the Cyp19a1 gene. In rat 
granulosa cells, CTNNB1 was shown to bind the transcription factor NR5A1 
(steroidogenic factor-1 (SF1)), resulting in the upregulation of CYP19A1 expression in 
vitro. Regulation of estrogen biosynthesis by FSH/cAMP requires a functional interaction 
between SF1 and CTNNB1 on the Cyp19a1 promoter. Decreasing β-catenin levels or 
disrupting the SF1 and β-catenin interaction decreases FSH/cAMP-induced Cyp19a1 
mRNA accumulation (Parakh et al., 2006). Challenging mouse and bovine granulosa cells 
with FSH could stimulate steroidogenic genes and enzymes via CTNNB1 activation 
(Castanon et al., 2012b, Fan et al., 2010b, Li et al., 2014). 
Based on these studies, we can conclude that CTNNB1 is an essential 
transcriptional regulator of CYP19A1 expression and consequently estradiol secretion.  
 
2.5.1.2 Follicle development    
In a recent study, CTNNB1 was shown to facilitate FSH-induced follicular growth 
and decrease follicular atresia. FSH and CTNNB1 signaling can synergistically promote 
the expression of genes required for granulosa cell proliferation and estrogen biosynthesis 
such as Cyp19a1, Nr5a1, Fshr and Ccnd2, and decrease Foxo1 which is a negative 
regulator of proliferation and steroidogenesis. On the other hand, CTNNB1 inhibited LH 
action and reduced fertility, ovulation, oocyte maturation, cumulus expansion, 
luteinization, and progesterone biosynthesis. These effects were mediated by the 
decreased the expression of genes involved in all of these processes, including Areg and 
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Ereg (Fan et al., 2010a). These findings indicate CTNNB1 can have profound effects on 
granulosa cell proliferation, differentiation, and survival. 
 
2.5.2 WNT4 
WNT4 activates different pathways according to cell type and physiological 
context. It has been observed to play a role in a wide variety of physiological and 
pathological events from embryogenesis to follicular development in the ovary (Franco et 
al., 2011). 
2.5.2.1 Embryonic development 
In mammals, the gonadal primordium is a unique tissue that is able to undergo two 
opposite fates to form either a testis or an ovary. It has been shown that WNT4 plays an 
important role in human and mouse sex determination (Hsieh et al., 2002). WNT4 is 
expressed in the early stages of embryonic development before differentiation in both 
female and male. However, its expression down regulated in the developing male gonad 
(11.5 days post-coitum in mice) and stays elevated in the developing ovary. Lack of 
WNT4 leads to masculinization of the XX embryo, which is characterized by including 
the persistence of the Wolffian duct. 
It has been shown that WNT4 inhibits the migration of adrenal precursors and 
endothelial cells into the ovary (Jeays-Ward et al., 2003). Wnt4-null mice ovaries express 
many Leydig and Sertoli cell markers and secrete testosterone and Müllerian-inhibiting 
substance (MIS) (Hsieh et al., 2002). WNT4 has a crucial role during embrogenesis in 
males as well as in females. Ablation of Wnt4 reduces the proliferation of the coelomic 
epithelium cells, decreasing the number of progenitors of Sertoli cells in XY mutant 
gonads, and leading to reduced numbers of Sertoli cells and the formation of a testis with 
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few seminiferous tubules. WNT4 is a regulator of cell proliferation in the early gonad 
regardless of its sex and has a specific role in ovarian differentiation (Chassot et al., 2012). 
In Wnt4 mutant mouse ovaries the number of oocytes is abnormally low by the time of 
birth. WNT4 has not been shown to affect the number of primordial germ cells in the 
undifferentiated gonad, but it seems to act as an oocyte survival factor during female 
embryogenesis (Vainio et al., 1999).  
One study has shown an essential role for WNT4 in normal postnatal uterine 
development and function. Ablation of Wnt4 leads to subfertility with defects in embryo 
implantation and endometrial stromal cell survival, differentiation and responsiveness to 
progesterone signaling (Franco et al., 2011). 
 
2.5.2.2 Follicle development     
WNT4 is expressed in small preantral follicles, preovulatory follicles, and corpora 
lutea in the rodent ovary. Wnt4 mRNA levels increase significantly in response to an 
ovulatory dose of hCG in rat and mouse granulosa cells, suggesting a role important in 
some aspects of late follicle development, ovulation, and/or luteinization (Hsieh et al., 
2002).   
Because Wnt4-null mice die shortly after birth due to kidney defects, granulosa 
cell-targeted conditional inactivation of Wnt4 was used to study its role in the ovary. 
Results showed that WNT4 is required for normal antral follicle development and can 
regulate granulosa cell functions. Wnt4(flox/-);Amhr2tm3(cre)Bhr/- mice were born with normal 
numbers of follicles, however they had fewer healthy antral follicles at puberty compared 
to controls. In addition, WNT4 was shown to regulate the expression of genes related to 
ovulation, including Adamts1 and Ptgs2, and the steroidogenic genes Cyp19a1, Cyp11a1 
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and Star (Boyer et al., 2010b). Another study showed that inactivation of Wnt4 in 
granulosa cells significantly reduced folliculogenesis and female fertility, and led to 
premature ovarian failure. These deficiencies were related to cell polarity defects in the 
follicles. Wnt4 deficiency reduces the expression of adherens junction and gap junction 
components and compromises follicular cell polarity. Therefore, WNT4 is important for 
maturation of ovarian follicles, cell survival, and polarized organization of the follicular 
cells (Prunskaite-Hyyrylainen et al., 2014). 
 
2.5.3 WNT2 
WNT2 is expressed in the developing pericardium, lung, and placenta. Ovarian 
steroids can modulate WNT2 expression in the endometrium and mammary gland. RT-
PCR and in situ hybridization (ISH) analyses indicate that Wnt2 is expressed in follicular 
granulosa cells in the immature rat ovary. Targeted disruption of the Wnt2 gene in mice 
results in placentation defects however, Wnt2-null mice did not show fertility problems, 
suggesting that it may not be essential for follicular function. (Ricken et al., 2002). 
Knockdown of WNT2 decreased DNA synthesis in granulosa cells, whereas 
WNT2 overexpression increased this process. WNT2 knockdown led to an accumulation 
of glycogen synthase kinase-3β in the cytoplasm and reduced the expression of CTNNB1. 
Conversely, WNT2 overexpression reduced the expression of GSK3β in the cytoplasm 
and induced β-catenin translocation from the membrane to the nucleus. CTNNB1 
knockdown also inhibited DNA synthesis in granulosa cells and neutralized the effect of 
WNT2 overexpression. This study therefore showed that WNT2 stimulates granulosa cell 
proliferation in vitro via the CTNNB1 pathway (Wang et al., 2010). The same group 
reported the WNT2/CTNNB1 pathway regulates connexin43 expression and gap-
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junctional intercellular communication in granulosa cells by modulating CTNNB1 
stability and localization in adherens junctions (Wang et al., 2013) 
In cultured b bovine granulosa cells, only WNT2 mRNA was induced after 24 h of 
FSH treatment among the WNT genes that were tested. In addition, western blot analysis 
determined that CTNNB1 expression was regulated by FSH in vitro. Therefore, FSH-
induced WNT2 signaling may be responsible for the up-regulation of CTNNB1 in bovine 
granulosa cells (Castanon et al., 2012a). 
 
2.5.4 FZD1 
Little is known about the functions of FZDs in the mammalian ovary. Fzd1 mRNA 
expression increased in PMSG treated mouse ovaries followed with hCG for 12h. FZD1 is 
not present on the surface of primary or small antral follicles, but is present on the surface 
of growing oocytes in late secondary follicles. This could indicate that FZD1 is involved 
in regulating gene expression during specific stages of follicle development (Harwood et 
al., 2008). FZD1 expression is first up-regulated in theca cells and then in granulosa cells 
of the ovulatory follicle by LH, however it is not detected in the corpora lutea of PMSG-
treated mice. The selective and transient induction of FZD1 in granulosa cells by LH 
suggested that, in the ovulating follicle, Fzd1 could regulate genes that impact follicle 
rupture or luteinization (Hsieh et al., 2002). Fzd1-/- females produced almost one less pup 
per litter compared to controls, indicating a significant role for FZD1 in female fertility. 
However, the numbers of follicles, expression of genes related to steroidogenesis and 
steroid hormone level were normal in Fzd1-null females. RT-qPCR analysis determined 
that FZD1 regulates genes related to cumulus expansion (Btc, Ptgs2, Sema3a, Ptx3, Il6, 
Nts and Alcam) and oocyte maturation (Zp3, Dppa3, Nlrp5 and Bmp15). However, 
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cumulus expansion was normal in Fzd1-/- COCs both in vitro and in vivo (Lapointe et al., 
2012). 
 
2.5.5 FZD4 
Fzd4 is expressed in pregnant and postpartum mouse ovaries. Wnt4 and Fzd4 are 
coexpressed in corpora lutea, suggesting that FZD4 could be a receptor for WNT4, and 
WNT4/FZD4 signaling may be important for regulation of luteal cell functions (Hsieh et 
al., 2002). It seems FZD4 is essential for normal fertility because both male and female of 
Fzd4-null mice are infertile. The latter mice had normal follicular development, ovulation 
and released mature oocytes. However, implantation never happened in Fzd4-null mice, 
and they failed to form functional corpora lutea. Defective luteal cell function appeared to 
be associated with inadequate angiogenesis (Hsieh et al., 2005). 
 
2.5.6 SFRP4 
SFRP4 is one of the members of the secreted FZD related protein (sFRP) family. 
The exact function of sFRP4 is still unclear, although sFRPs have generally been 
described as WNT antagonists. sFRP4 expression was detected in the ovary of mice and 
rats (Hsieh et al., 2002). In the rodent model, sFRP4 was shown to be induced by LH 
independent of the progesterone receptor, and was also upregulated by prolactin (PRL) in 
granulosa cells. Regulation of SFRP4 by LH and PRL may be essential for regulation of 
FZD1, which is known to be expressed in preovulatory follicles, and WNT4/FZD4, which 
are expressed in corpora lutea (Hsieh et al., 2003). One study reported that human sFRP4 
decreased as follicles grow to the preovulatory stage and its expression was higher in 
cumulus cells than in mural granulosa cells. In addition, sFRP4 expression was inhibited 
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by LH/hCG stimulation in vivo and in cell culture. These results show that sFRP4 might 
have role in follicular development and ovulation (Maman et al., 2011).  
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Chapter 2. Hypotheses and 
objectives 
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2. 1 Hypotheses and objectives 
Recent reports have suggested roles of canonical WNTs signaling in the adult 
ovary. Canonical WNTs appear to play central roles in normal follicle development, and 
act to regulate granulosa cell functions including steroidogenesis and proliferation. Most 
of the information available about WNT signaling in the ovary has been derived from 
rodents. Whether WNTs play similar roles in large monovular species such as the cow 
remains essentially unknown. Therefore, my first hypothesis is that WNT signaling may 
be important for follicular development and steroidogenesis in bovine granulosa cells. 
In addition, little is known about the role of non-canonical WNT signaling in the 
ovary. WNT5a and WNT11 are the two best-known non-canonical WNT members and are 
expressed in mouse granulosa cells, however their roles in the adult ovary are unknown. 
Therefore, the second hypothesis is that WNT5a and WNT11 are critical for follicle 
development and act in granulosa cells via a non-canonical signaling pathway.  
To test our hypotheses, we established the following objectives for the present 
thesis: 1) To elucidate the hormonal regulation of major WNTs and their physiological 
roles in bovine granulosa cells in vitro. The results corresponding to this objective are 
described in chapter 3. 
2) To identify the physiological roles of WNT5a and WNT11 by conditional gene 
inactivation in mouse granulosa cells, as well as their mechanisms of action. The data 
related to this objective are described in chapter 4. 
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3.2 Abstract 
The WNT family has been implicated in follicular development in rodents, 
however, the role of WNTs in the follicle of monovulatory species is poorly understood. 
The objective of this study was to determine the potential roles of WNTs in bovine 
granulosa cell function. Cells cultured in serum-free medium expressed mRNA encoding 
WNT2B, WNT5B and WNT5A. Levels of WNT5A, but not of WNT2B or WNT5B mRNA 
were down-regulated by FSH. Addition of WNT5A to cultured cells suppressed FSH-
stimulated estradiol and progesterone secretion, and levels of mRNA encoding the 
steroidogenic enzymes CYP19A1, CYP11A1 and the FSH receptor, but had no effect on 
cell proliferation or apoptosis. Immunoblot experiments showed that WNT5A reduced 
activation of CTNNB1 and stimulated phosphorylation of MAPK8 and JUN proteins. We 
conclude that WNT5A is a negative regulator of FSH-stimulated granulosa cell 
steroidogenesis, and that it acts by suppressing canonical WNT signaling activity and 
inducing the non-canonical MAPK8/JUN pathway. 
Key words: WNT5A, steroidogenesis, granulosa cells, bovine 
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3.3 Introduction 
Although the gonadotropins, FSH and LH, are the main endocrine regulators of 
ovarian follicle growth and development, a number of paracrine and autocrine factors 
modulate the response of follicle cells to gonadotropin signals (Richards et al., 2002). 
These include the transforming growth factor β family, the insulin-like growth factor 
family and the fibroblast growth factor family (Buratini and Price, 2011). Another large 
group of factors that has been linked to the reproductive system is the wingless-type 
mouse mammary tumor virus integration site (WNT) family. 
In mammals, 19 different WNT proteins have been described, and have been 
reported to control diverse developmental processes such as cell fate specification, 
proliferation, differentiation and apoptosis in a wide range of tissues including the ovary 
(Boyer et al., 2010a; Cadigan and Nusse, 1997; Wang et al., 2012). Secreted WNT 
proteins are hydrophobic and travel short distances within the extracellular matrix, and it 
has become increasingly apparent that WNTs are secreted in exosomes (Zhang and 
Wrana, 2014); it is thus likely that WNTs act in an autocrine or juxtacrine manner. WNTs 
transduce their signals by binding to G protein-coupled receptors of the Frizzled (FZD) 
family and the lipoprotein-related receptor proteins LRP5 and LRP6 that act as co-
receptors at the cell surface (Lapointe et al., 2012). The WNT-FZD complex transduces a 
signal via disheveled (DVL) to activate at least three distinct intracellular signaling 
pathways known as the canonical pathway, the planar cell polarity (PCP) pathway, and the 
WNT/Ca2+ pathway (Boerboom et al., 2005; Karner et al., 2006; Kohn and Moon, 2005). 
The pathway that is activated by a given WNT is determined by cell type, the composition 
of the receptor complex and the WNT ligand itself (Kühl et al., 2000). In the canonical 
pathway, the binding of a WNT ligand to the receptor complex results in the 
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hypophosphorylation, stabilization and accumulation of the signaling effector β-catenin 
(CTNNB1) in the cytoplasm. CTNNB1 can then translocate to the nucleus, where it 
associates with a number of transcription factors to alter the transcriptional activity of 
target genes (Boyer et al., 2010a; Lapointe and Boerboom, 2011). In the PCP pathway, 
WNT binding activates two parallel pathways involving the small GTPases RHO and 
RAC (Wallingford and Habas, 2005). The RHO branch of signaling activates RHO-
associated kinase (ROCK) (Marlow et al., 2002; Weiser et al., 2007), and the RAC 
signaling branch stimulates JUN kinase (MAPK8) activity (Habas et al., 2003; Li et al., 
1999). According to the prevailing view, ROCK and MAPK8 then act via different 
effectors mainly to modify the actin cytoskeleton leading to cytoskeletal rearrangement 
(Keller et al., 2003). However, MAPK8-mediated phosphorylation of the transcription 
factor JUN also occurs in PCP pathway signaling in certain contexts, resulting in the 
transcriptional activation of target genes (Saadeddin et al., 2009; Semenov et al., 2007). 
Most of the information available about WNT signaling in the ovary has been 
derived from rodents. Messenger RNA encoding several WNT proteins has been detected 
in the ovary, including Wnt2, Wnt3a, Wnt4 and Wnt5a (Hsieh et al., 2002; Ricken et al., 
2002). The canonical Wnt4 is expressed in granulosa cells and corpora lutea in mice 
(Hsieh et al., 2002) and is essential for the development of the ovary and follicles (Boyer 
et al., 2010a). Granulosa cell-specific knockout of Wnt4 decreased luteal progesterone 
synthesis and levels of mRNA encoding steroidogenic acute regulatory protein (Star), 
cytochrome P450 side-chain cleavage (Cyp11a1) and cytochrome P450 aromatase 
(Cyp19a1) and, conversely, overexpression of Wnt4 in mouse granulosa cells increased 
abundance of mRNA of these same genes (Boyer et al., 2010b). Wnt2 is also expressed in 
rat granulosa cells, and was shown to stimulate granulosa cell proliferation in vitro via the 
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CTNNB1 pathway (Ricken et al., 2002; Wang et al., 2010). (Finnson et al., 2012) but its 
role in vivo has not yet been established. 
Much less is known about the expression and function of ovarian WNTs in 
monovulatory species. In humans, WNT2 but not WNT4 mRNA was detected in cumulus 
cells (Wang et al., 2009), whereas WNT4 and WNT5A transcripts have recently been 
reported in luteinized granulosa cells (Sanchez et al., 2014). In luteinized bovine granulosa 
cells, WNT2 mRNA was detected and upregulated by FSH (Castañon et al., 2012), and 
CTNNB1 has been shown to act downstream of LH to regulate STAR expression and 
progesterone synthesis (Roy et al., 2009). To our knowledge, there are no reports of WNT 
expression in non-luteinized granulosa cells of a monovulatory species. The objectives of 
the present report were to determine the expression profile of selected WNTs in non-
luteinizing bovine granulosa cells, and to test the hypothesis that WNTs alter bovine 
granulosa cell physiology and steroidogenesis. 
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3.4 Material and methods: 
3.4.1 Cell culture 
All materials were obtained from Life Technologies Inc. (Burlington, ON, Canada) 
unless otherwise stated. Bovine granulosa cells were placed into a well-defined serum-free 
culture system in which the cells are estrogenic and respond to FSH but not to LH 
(Gutiérrez et al., 1997; Sahmi et al., 2004; Silva and Price, 2000). Briefly, bovine ovaries 
were collected at an abattoir from adult cows irrespective of stage of the estrous cycle, and 
transported to the laboratory at 30 ºC in phosphate-buffered saline (PBS) containing 
penicillin (100 IU/ml), streptomycin (100 mg/ml), and fungizone (1 mg/ml). Follicles 
between 2 and 5 mm in diameter were dissected from the ovary and each one was cut into 
six to eight pieces and granulosa cells recovered by rinsing the follicle wall with medium; 
cells were washed twice by centrifugation at 980×g for 20 min each, and the cell 
suspension was filtered through a 150 mesh steel sieve (Sigma–Aldrich Canada, Oakville, 
ON, Canada). The number of cells was counted with a hemocytometer and cell viability 
was assessed by the dye exclusion method using 0.4% Trypan Blue. Cells were placed 
into 24-well tissue culture plates (Sarstedt Inc., Newton, NC) at a density of 106 viable 
cells in 1 ml DMEM/F12 containing sodium bicarbonate (10 mmol/L), sodium selenite (4 
ng/ ml), bovine serum albumin (BSA) (0.1%; Sigma–Aldrich), penicillin (100 U/ml), 
streptomycin (100 mg/ml), transferrin (2.5 mg/ml), nonessential amino acid mix (1.1 
mmol/L), bovine insulin (10 ng/ml), androstenedione (10-7 M), and bovine FSH (1 ng/ml 
unless otherwise stated; lot AFP-5332B, NIDDK). Cultures were maintained at 37ºC in 
5% CO2, 95% air for 6 days, with 70% of the culture medium being replaced every 2 
days. 
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To study the effect of FSH on WNT expression, cells were treated without and 
with graded doses (0, 0.1, 0.5, 1 ng/ml) of FSH on day 2 of culture. The effects of 
WNT5A on granulosa cells was tested by culturing cells with 1 ng/ml FSH and adding 
graded doses of recombinant human WNT5A (R&D Systems, Minneapolis, MN). 
Medium samples were collected on day 6 and stored at −20 ◦C until steroid assay, and 
cells were collected in Trizol and stored at−80 ◦C until RNA extraction. 
To determine target genes and pathways activated by WNT5A, cells were treated 
with WNT5A (500 ng/ml) on day 5 of culture for 0, 1, 2, 4 and 6 h (for RNA extraction) 
or for 0, 1, 5, 30 and 120 min (for protein extraction). Specific signaling inhibitors were 
also used to dissect the major signaling pathway activated by WNT5A. The inhibitors 
were AS601245 (Calbiochem) an inhibitor of MAPK8 and NSC23766 (R&D Systems, 
Minneapolis, MN) an inhibitor of Rac GTPase, which acts upstream of MAPK8. The first 
inhibitor was dissolved in DMSO and the second with water, then directly added to the 
medium. The cells were pretreated with inhibitors for 1 h before addition of WNT5A for a 
further 1 h for RNA extraction and 0.5 h for protein extraction. Controls were treated with 
DMSO and water. All series of cultures were performed on at least three different pools of 
cells collected on different occasions. 
 
3.4.2 Assessment of granulosa cell proliferation and apoptosis 
Cells were cultured as described above and treated with 0 or 125 ng/ml WNT5A 
for the 2 last days of culture. Cell cycle analysis was performed by resuspending the cells 
in Krishan’s buffer (0.05 mg/ml propidium iodide, 0.3% nonidet (NP-40), 0.1% sodium 
citrate, and 0.02 mg/ml RNAse) for 1 h on ice, followed by flow cytometric analysis. For 
each sample, 10,000 propidium iodide stained cells were analysed on a FACSCalibur (BD 
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Biosciences) using Cellquest Pro acquisition software. The Annexin V-FITC Apoptosis 
assay (Sigma–Aldrich Canada, Oakville, ON, Canada) was used to determine the 
percentage of early and late apoptotic cells. Cells were washed twice with PBS and then 
resuspended in binding buffer and processed according to the manufacturer’s instructions. 
 
3.4.3 In vivo study 
To determine if WNT5A expression differs between dominant and subordinate 
follicles in vivo, the emergence of a follicle wave was synchronized by an injection of 
prostaglandin F2, and the ovaries were recovered at slaughter on days 2 to 4 of the 
wave. The two largest follicles were dissected from each pair of ovaries, their diameters 
were measured, and the follicular fluid was aspirated, centrifuged, and frozen for steroid 
assay. The antral cavity was repeatedly flushed with cold saline solution and granulosa 
cells recovered by centrifugation at 1200 x g for 1 min and pooled with the follicular fluid 
pellet. The dominant follicle in each animal was identified by size, follicular fluid 
estradiol concentration and evaluation of mRNA encoding CYP19A1 in granulosa cells; 
the estradiol data and detailed methods have been previously reported (Portela et al., 
2010a). 
 
3.4.4 Total RNA extraction and real-time RT-PCR 
After treatments, the culture medium was removed and total RNA was extracted 
using Trizol as instructed by the manufacturer. Total RNA (1 μg) was treated with 1 U 
DNase (Promega, Madison, WI, USA) at 37 ◦C for 5 min to digest any contaminating 
DNA, and then reverse-transcribed with 4 U Omniscript RTase (Qiagen, Mississauga, ON, 
Canada) in the presence of 1 mmol/l oligo(dT) primer, 0.25 mmol/l dideoxynucleotide 
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triphosphate (dNTP) mix and 19.33 U RNase Inhibitor (GE Healthcare, Baie D’Urfé, QC, 
Canada) in a volume of 20 μl at 37ºC for 1 h. The reaction was terminated by incubation 
at 93 ºC for 3 min. Real-time PCR was performed on a 7300 Real-Time PCR system 
(Applied Biosystems, Streetsville ON, Canada) with Power SYBR Green PCR Master 
Mix. Bovine-specific primers for H2AFZ (Portela et al., 2010b), CYP19A1 (Hamel et al., 
2005), FSHR (Luo and Wiltbank, 2006), HSD17B1 (Portela et al., 2010a) and FOS (Jiang 
et al., 2013) were previous used by us, those for CYP11A1, HSD3B1, STAR (Orisaka et al., 
2006) and JUN (Atli et al., 2012) were as described by others. Bovine-specific WNT 
primers were designed with Primer Express (Applied Biosystems, Foster City, CA) and 
are: WNT4, forward 5'-CATGAACCTCCACAACAACGA-3', reverse 5'-
TCGCCAGCACGTCTTTACCT-3'; WNT2, forward 5'-
CCAGAGCCCTGATGAATCTTCA-3', reverse 5'-TCACGCCATGACACTTGCA-3'; 
WNT2B, forward 5'- GACCGGGACCACACTGTCTT-3', reverse 5'-
GACCACCCCTGCTGATGAGA-3'; WNT5A, 5'-TTCTCTCCTTCGCCCAGGTT-3', 
reverse 5'-AGAGAGGCTGCGCTCCTATG-3'; WNT5B, forward 5' 
CCGCGTGCTCATCATGAACCT-3', reverse, 5'-GAGACGCCATGGCATTTGC-3'. 
Common thermal cycling parameters (3 min at 95 ºC, 40 cycles of 15 s at 95ºC, 30 s at 59 
ºC, and 30 s at 72ºC were used to amplify each transcript. Amplicons obtained from 
original primers were sequenced to confirm identity, and melting-curve analyses were 
performed in each assay. Samples were run in duplicate and were normalized to histone 
2AFZ (H2AFZ). The RT-PCR data obtained with this method were presented as fold 
increases in gene expression relative to a reference sample for each gene analyzed. Data 
were normalized to a calibrator sample using the ΔΔCt method with correction for 
amplification efficiency (Pfaffl, 2001). 
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3.4.5 Immunoblotting 
After treatment, granulosa cells were washed with ice-cold PBS and lysed in 50 
μl/well ice-cold RIPA buffer (25 mM Tris– HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% 
sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate, and protease inhibitor 
cocktail). The homogenate was centrifuged at 6000g for 5 min at 4 C and the supernatant 
stored at -80 ºC. Protein concentrations were determined by BCA protein assay (Pierce, 
Rockford IL). Samples (15 μg total protein) were loaded onto 10% SDS-polyacrylamide 
gels in SDS loading buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 1% β-
mercaptoethanol, 12.5 mM EDTA, and 0.02% bromophenol blue), electrophoresed and 
electrotransferred to Hybond-P PVDF membrane (GE Amersham, Piscataway, NJ) in 39 
mM glycine, 48 mM Tris-base, 1% SDS, 20% methanol, pH 8.3. After transfer, the 
membranes were blocked in 5% non-fat dry milk in TTBS (10 mM Tris–HCl, 150 mM 
NaCl, 0.1% Tween-20, pH 7.5) for 1 h. Membranes were incubated overnight with the 
primary against WNT5A (cat # ab72583 1:1000 , Abcam Inc, Toronto, Canada), active 
CTNNB, (cat # 8814, 1:1000, all the following antibodies from Cell Signaling 
Technology, Danvers, MA) total CTNNB, (cat # 8480, 1:1000), phospho-MAPK8, (cat # 
9251, 1:1000), MAPK8, (cat # 9252, 1:1000), phospho-JUN (cat #2361, 1:500) or JUN, 
(cat # 9165, 1:500) diluted in 5% bovine serum albumin. After washing three times with 
TTBS, membranes were incubated for 1 h at room temperature with 1:10,000 anti-rabbit 
HRP-conjugated IgG (GE Healthcare Canada) diluted in 5% non-fat dry milk in TTBS. 
The protein bands were visualized by chemiluminescence (ECL; Millipore, Billerica MA) 
and quantified using a Vilber Lourmat Fusion Fx chemiluminescence detection system. 
Active CTNNB and phospho MAPK8 levels were expressed relative to total CTNNB and 
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MAPK8 levels, respectively, and phosphorylated and total JUN levels were expressed 
relative to ACTB levels. 
 
3.4.6 Steroid Assay 
Steroid concentrations in the culture medium were corrected for cell number by 
expressing the data per unit mass of total cell protein. Cells were lysed with 100 μl of 1N 
NaOH for 2 h and neutralized with 100μl of 1N HCl, and total cell protein was measured 
by the Bradford protein assay (Bio-Rad, Mississauga, ON, Canada). Estradiol was 
measured in follicle fluid and in conditioned medium in duplicate as described (Bélanger 
et al., 1990) without solvent extraction. Intra- and interassay coefficients of variation were 
6% and 9%, respectively. Progesterone was measured in conditioned medium in duplicate 
as described (Lafrance and Goff, 1985), and mean intra- and interassay coefficients of 
variation were 7.2% and 18%, respectively. The sensitivity of these assays was 10 pg and 
4 pg per tube for estradiol and progesterone, equivalent to 0.3 and 20 ng/μg protein, 
respectively. 
 
3.4.7 Statistical analysis 
All statistical analyses were performed with JMP software (SAS Institute, Cary, 
NC). Data were transformed to logarithms if they were not normally distributed (Shapiro–
Wilk test). Proportions of cells at each stage of the cell cycle were arcsine transformed 
before analysis. ANOVA was used to test the main effects of treatments, and culture 
replicate was included as a random variable in the F-test. Differences between means were 
tested with Fisher's protected test. The data are presented as least square means ± SEM. 
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3.5 Results 
3.5.1 WNT expression in bovine granulosa cells 
We first surveyed WNT gene expression in bovine granulosa cells using a non-
luteinizing culture model. Messenger RNA encoding WNT2B (average Ct value, 27), 
WNT5B (Ct, 28) and WNT5A (Ct, 27) were detected, but those encoding WNT4 (Ct, 40) 
and WNT2 (Ct, 38) were at minimum detectable levels. To examine the regulation of 
WNT expression, granulosa cells were cultured with graded doses of FSH (0, 0.1, 0.5, 1 
ng/ml); WNT2B and WNT5B mRNA levels were not affected by FSH (data not shown), 
whereas WNT5A mRNA levels were significantly decreased by FSH (Fig 1A). Western 
blotting demonstrated that FSH also decreased WNT5A protein levels in granulosa cells 
(Fig 1A). We then determined whether altered WNT5A mRNA abundance occurs in vivo 
by assaying granulosa cells of well-characterized dominant compared to subordinate first-
wave follicles: WNT5A mRNA levels were significantly lower in granulosa cells from 
dominant compared with subordinate follicles (Fig 1B). 
 
3.5.2 WNT5A suppressed the effects of FSH on steroid secretion and steroidogenic 
enzyme gene expression. 
As WNT5A was regulated during follicle development, we then focused on the 
actions of this WNT. Cultured bovine granulosa cells were challenged with FSH, 
recombinant human/mouse WNT5A (500 ng/ml), neither or both for 2 days. As expected, 
FSH significantly increased estradiol secretion and CYP19A1 mRNA levels with minimal 
effects on progesterone secretion and CYP11A1 and FSHR mRNA levels. Alone, WNT5A 
had no effect on estradiol secretion or CYP19A1 mRNA levels, but potently suppressed 
the stimulatory effect of FSH on estradiol secretion and CYP19A1 mRNA levels (Fig 2). 
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Addition of WNT5A alone significantly inhibited FSHR mRNA levels (Fig 2), and this 
was not overcome by the addition of FSH (Fig 2). Either FSH or WNT5A alone inhibited 
STAR mRNA levels, and combined there was no further reduction. 
A subsequent dose-response experiment demonstrated that WNT5A inhibited 
FSH-stimulated steroid secretion at the lowest dose tested (62.5 ng/ml), and CYP19A1 and 
CYP11A1 mRNA levels were decreased with doses of 125 ng/ml and higher 
(Supplemental Fig 1). WNT5A had no significant effect on FSH-stimulated STAR or 
HSD17β1 mRNA levels even at 500 ng/ml (Supplemental Fig 1). 
 
3.5.3 WNT5A does not affect the cell cycle or apoptosis 
The relatively high levels of WNT5A mRNA in granulosa cells of subordinate 
follicles and the ability of WNT5A to inhibit estradiol secretion prompted us to determine 
the effect of WNT5A on granulosa cell health. Addition of an effective dose of WNT5A 
(125 ng/ml) had no effect on progression through the cell cycle or on the incidence of 
apoptotic cells (Table 1). Further, WNT5A did not alter abundance of mRNA encoding 
the cell cycle marker CCDN2, or of the apoptosis-related genes FASLG or GADD45B (not 
shown). 
 
3.5.4 WNT5A acts through the PCP pathway 
Immunoblot experiments were performed to identify the predominant signaling 
pathways used by WNT5A in FSH-stimulated bovine granulosa cells. Abundance of 
active β-catenin was significantly reduced by the addition of WNT5A (Fig 3A), whereas 
WNT5A resulted in a transient increase in MAPK8 phosphorylation (Fig 3B) and in the 
abundance of both phosphorylated and total JUN proteins (Fig 3C). 
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The importance of the PCP pathway was investigated with the use of a competitive 
inhibitor of MAPK8 activity (AS601245) and by inhibition of Rac1 GDP/GTP exchange 
activity with NSC23766. Neither inhibitor alone altered total or phospho-JUN abundance, 
but each significantly reduced WNT5A-stimulated JUN phosphorylation without a 
significant effect on total JUN abundance (Fig 4). Inhibition of MAPK8 activity also 
increased β-catenin activation (Fig 4). 
Targets of MAPK8 include FOS and JUN genes, therefore we determined whether 
WNT5A increases levels of mRNA encoding these transcription factors. WNT5A rapidly 
and transiently increased abundance of mRNA encoding JUN and FOS (Fig 5A). 
Consequently, we explored the role of PCP pathway on JUN and FOS mRNA abundance; 
inhibition of the MAPK8 pathway with AS601245 prevented WNT5A from stimulating 
JUN and FOS mRNA levels, and treatment with the Rac1 inhibitor NSC23766 inhibited 
the stimulatory effects of WNT5A on JUN and blunted the effect of WNT5A on FOS 
mRNA levels (Fig 5B). 
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3.6 Discussion 
Canonical WNT signaling has been previously described in the rodent ovary. In 
the present study, we provide compelling evidence for a non-canonical WNT signaling 
pathway in bovine granulosa cells, and that this signaling regulates estradiol secretion and 
may be involved in follicle function. Our evidence suggests that WNT5A is one ligand 
that activates this pathway. 
Messenger RNA encoding WNT5A has previously been detected in human 
granulosa cells (Sanchez et al., 2014), and we could readily detect mRNA and protein in 
bovine granulosa cells. Abundance of WNT5A mRNA was regulated by FSH, whereas 
WNT2B and WNT5B mRNA levels were not, which points to a specific regulation of 
WNT5A in the ovary. Other reports of WNT regulation in granulosa cells show that FSH 
stimulates abundance of mRNA encoding Wnt2 and Wnt4 (Castañon et al., 2012; Hsieh et 
al., 2002), therefore this is the first description of the negative regulation of a WNT by 
FSH. The reduction of WNT5A mRNA was reflected by a reduction of WNT5A protein 
levels, indicating that altered mRNA abundance has potential physiological relevance. 
This is supported by the increased levels of WNT5A mRNA in subordinate compared with 
dominant first-wave follicles; the dominant follicle avoids regression because it is able to 
maintain gonadotrophic signaling (through FSH and/or IGF1), and this signaling likely 
results in the lower WNT5A mRNA levels observed. 
The main signaling pathway activated by WNT5A is a non-canonical pathway 
(reviewed in (Kikuchi et al., 2012)), although as WNT5A has been reported to activate 
CTNNB signaling in the presence of FZD4 (Mikels and Nusse, 2006) and as FZD4 
mRNA is present in granulosa cells (Ricken et al., 2002), we verified which pathway is 
activated by WNT5A in bovine granulosa cells. Western blot experiments clearly show 
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that WNT5A did not increase the abundance of active CTNNB protein, but increased 
MAPK8 and JUN phosphorylation and abundance of mRNA encoding the phospho-JUN 
transcriptional targets, JUN and FOS, which are components of the PCP pathway. The 
increase in JUN mRNA levels was reflected by an increase in JUN protein levels. These 
data are consistent with studies showing that knock-down of WNT5A decreased phospho-
JUN levels in a sarcoma cell line (Jin et al., 2012) and that WNT5A upregulated phospho-
JUN levels in NIH3T3 fibroblasts (Nomachi et al., 2008). Pharmacological inhibition of 
MAPK8 or Rac1 blocked the ability of WNT5A to stimulate phosphorylation of JUN and 
expression of JUN and FOS (present study). Collectively, these data demonstrate that 
WNT5A signals through the non-canonical PCP pathway in bovine granulosa cells. 
Not only did WNT5A fail to activate CTNNB in granulosa cells, but it also 
decreased active CTNNB protein levels. Previous reports have demonstrated that 
treatment with WNT5A decreases total CTNNB protein levels and/or CTNNB1 signaling 
in luteinized human granulosa cells as well as other cell types (Pourreyron et al., 2012; 
Sanchez et al., 2014; Sato et al., 2009; Topol et al., 2003). Several mechanisms have been 
proposed to explain how non-canonical WNTs may antagonize the canonical pathway, 
including direct competition with canonical WNTs for binding to FZD receptor complexes 
(Bryja et al., 2009), increasing the expression of SIAH ubiquitin ligase and accelerating 
ubiquitination and degradation of CTNNB1 (Topol et al., 2003), and inhibiting coactivator 
recruitment to the promoters of target genes via a protein kinase C pathway (Lee et al., 
2010). The inhibitor studies in the present experiment suggest that MAPK8 signaling is at 
least part of the mechanism by which WNT5A inhibits active CTNNB1 levels. 
Addition of WNT5A to granulosa cells in culture decreased the secretion of 
estradiol and CYP19A1 and FSHR mRNA levels, all of which are under positive 
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regulation by FSH. The exact mechanism used by WNT5A to suppress FSHR, CYP19A1, 
CYP11A1 and STAR mRNA levels remains unclear. Exogenous JUN protein binds to the 
human ovarian CYP19A1 promoter and decreases transcriptional activity (Ghosh et al., 
2005), whereas CTNNB1 is known to stimulate Cyp19a1 expression and estrogen 
synthesis in rodent granulosa cells in vitro by binding to the transcription factor NR5A1 
(Hernandez Gifford et al., 2009; Parakh et al., 2006); thus by suppressing CTNNB1 and 
stimulating JUN, WNT5A likely contributes to the suppression of estradiol synthetic 
capacity through both PCP and CTNNB1 signaling pathways. However, this may not hold 
true for the inhibition of STAR mRNA by WNT5A, as CTNNB1 and JUN have both been 
shown to stimulate STAR mRNA in bovine corpus luteum (Roy et al., 2009) and mouse 
Leydig cells, respectively (Manna and Stocco, 2008; Martin and Tremblay, 2009). This 
suggests that WNT5A-induced suppression of active CTNNB1 levels had a negative 
impact on STAR mRNA levels that was not compensated for by the increase in JUN 
activity. 
Our PCR survey failed to detect WNT4 mRNA in bovine granulosa cells, which is 
in agreement with a study in human cumulus cells (Wang et al., 2009) but in contrast to 
studies with human luteinized granulosa cells and rodent ovaries (Hsieh et al., 2002; 
Sanchez et al., 2014). We also failed to detect significant quantities of WNT2 mRNA, 
unlike previous studies in bovine and rodent granulosa cells (Castañon et al., 2012; Ricken 
et al., 2002). One possible explanation for the discrepancy with the previous cow study is 
the differentiation status of the cultured cells, as Castañon et al. (Castañon et al., 2012) 
cultured cells with serum under luteinizing conditions. 
In summary, the results of the present study point to a novel role for a non-
canonical WNT pathway in follicle function. A possible scenario during the induction of 
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follicle atresia is that peripheral FSH concentrations decline, causing an increase in 
WNT5A expression. WNT5A decreases estradiol secretion and CYP19A mRNA levels in 
granulosa cells, likely through increased JUN and decreased CTNNB activities, and may 
act as an endogenous brake to steroidogenesis. A likely model to explain the role of 
WNT5A in the inhibition of canonical cascade and activation of non-canonical pathway is 
illustrated in the graphical abstract. Combined with a decline in factors supporting cell 
health (such as IGF1), WNT5A may thus contribute to the process of granulosa cell 
apoptosis and follicle regression. 
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3. 8 Figures 
 
 
 
Figure 1. Regulation of WNT5A in granulosa cells.  
(A) Effect of FSH on WNT5A mRNA and WNT5A protein levels in granulosa cells 
cultured under serum-free conditions (see Materials and Methods for details). (B) WNT5A 
mRNA levels in granulosa cells of dominant (n=4) or subordinate (n=4) follicles 
recovered on days 2-4 of an induced follicle wave. Steady-state mRNA levels were 
measured by real-time PCR and expressed relative to a calibrator sample with the ΔΔCt 
method. Protein abundance was measured by Western blot and expressed relative to ß-
actin protein abundance. Culture data are means ± SEM of three independent cultures, and 
bars with no common letters are significantly different (P<0.05). 
Figure 1. 
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Figure 2. 
 
 
 
Figure 2. Effect of WNT5A on steroidogenesis and on steady-state levels of mRNA 
encoding steroidogenic proteins in bovine granulosa cells. 
Granulosa cells from 2-5 mm follicles were cultured in serum-free medium for 6 days with 
and without FSH (1 ng/ml), and WNT5A (500 ng/ml) was added for the last 2 days of 
culture. Steady-state mRNA levels were measured by real-time PCR and expressed relative 
to a calibrator sample with the ΔΔCt method. Data are means ± SEM of three independent 
cultures, and bars with no common letters are significantly different (P<0.05). 
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Figure 3. 
 
 
Figure 3. WNT5A modulates the activity of multiple signaling pathways in bovine 
granulosa cells. Cells were cultured in serum-free medium with FSH for 5 days, and 
challenged with WNT5A (500 ng/ml) for the times shown. Total cell protein was used to 
measure total and active β-catenin, total and phosphorylated JNK, and total and 
phosphorylated JUN by Western blot; a blot from one replicate is shown and the samples 
are in the same order as in the graph. Data are means ± SEM of three independent 
replicates. Means without common letters are significantly different (P < 0.05).  
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Figure 4. WNT5A induced JUN phosphorylation is dependent on JNK and Rac1 activity. 
Granulosa cells were treated with inhibitors of Rac1 (NSC23766; NSC) or JNK 
(AS601245; AS) for 1 h before challenge with WNT5A (500 ng/ml) for 30 min. Western 
blot analyses were performed to detect total and phosphorylated JUN. Data are means ± 
SEM of three independent replicates. Bars without common letters are significantly 
different (P < 0.05). 
 
 
Figure 4. 
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Figure 5. WNT5A upregulates JUN and FOS mRNA abundance in granulosa cells through 
the PCP pathway. (A) WNT5A transiently increased abundance of mRNA encoding JUN 
and FOS. (B) Inhibition of JNK with AS601245 (AS) or Rac1 with NSC23766 (NSC) 
abrogated the effect of WNT5A on JUN and FOS mRNA abundance. Cells were treated 
with inhibitors for 1 h before challenge with WNT5A (500 ng/ml) for 1 hour. Data are 
means ± SEM of three independent replicates. For each mRNA, means without common 
letters are significantly different (P < 0.05). 
 
 
 
Figure 5. 
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Figure 6. Graphical abstract (for review) 
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3.9 Supplemental figure  
Figure S1. 
 
 
Figure S1. WNT5A inhibited steroid secretion and abundance of mRNA encoding 
CYP19A1 and CYP11A1 in a dose-dependent manner. 
Bovine granulosa cells were cultured in serum-free medium with FSH (1 ng/ml), and 
challenged with graded doses of WNT5A for the 2 last days of culture. Abundance of 
mRNA was measured by real-time PCR. Data are means ± SEM of three independent 
replicates. For each mRNA, means without common letters are significantly different (P < 
0.05). No letters indicates no significant effect of treatment. 
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3.10 Tables 
Table 1. Primer sequences used in real-time PCR. 
Gene Forward primer (5´- 3´) Reverse primer (3´- 5´) 
WNT4 CATGAACCTCCACAACAACGA TCGCCAGCACGTCTTTACCT 
WNT2 CCAGAGCCCTGATGAATCTTCA TCACGCCATGACACTTGCA 
WNT2B GACCGGGACCACACTGTCTT GACCACCCCTGCTGATGAGA
WNT5B CCGCGTGCTCATCATGAACCT GAGACGCCATGGCATTTGC 
WNT5A TTCTCTCCTTCGCCCAGGTT AGAGAGGCTGCGCTCCTATG
 
 
Table 2. Effect of WNT5a on the cell cycle, CCND2 mRNA levels and apoptosis in 
bovine granulosa cells. 
Variable WNT5A  (ng/ml) 
 0 125 
Sub-G1 (%) 15 ± 1 18 ± 1 
G0/G1 (%) 74 ± 2 72 ± 2 
S (%) 6 ± 0.5 6 ± 0.5 
G2/M (%) 4 ± 0.5 2 ± 0.5 
CCND2 mRNA (relative units) 0.9 ± 0.1 1.1 ± 0.2 
Apoptosis (%)* 24 ± 2 29.5 ± 2 
* As measured by Annexin V-FITC staining. 
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4.1 Article 2 
WNT5a is required for normal ovarian follicle development and antagonizes 
gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling 
 
Atefeh Abedini1, Gustavo Zamberlam1, Evelyne Lapointe1, Catherine Tourigny1, 
Alexandre Boyer1, Marilène Paquet1, Kanako Hayashi2, Hiroaki Honda3, Akira Kikuchi4, 
Christopher Price1, Derek Boerboom1. 
 
1. Centre de recherche en reproduction animale, Faculté de médecine vétérinaire, 
Université de Montréal, Saint-Hyacinthe, QC, Canada. 
2. Department of Pathology, Southern Illinois University School of Medicine, Carbondale, 
Illinois. 
3. Department of Disease Model, Research Institute of Radiation Biology and Medicine, 
Hiroshima University, Minami-ku, Hiroshima, Japan. 
4. Department of Molecular Biology and Biochemistry, Graduate School of Medicine, 
Osaka University, 2-2 Yamadaoka, Suita 565-0871, Japan. 
 
Author contributions: 
A.A., C.A.P., and D.B designed research; A.A., G.Z., E.L., M.P., C.T., and A.B perform 
research; A.A. analyzed data; K.H., H.H., and A.K provided mice; A.A., and D.B. wrote 
the paper. 
 
This manuscript will be submitted to the FASEB Journal 
 
 
 
 
102 
 
 
 
 
4.2 Abstract  
Whereas the roles of the canonical WNT signaling pathway in the regulation of ovarian 
follicle growth and steroidogenesis are now established, non-canonical WNT signaling in 
the ovary has been largely overlooked.  Non-canonical WNTs including WNT5a and 
WNT11 are expressed in granulosa cells and differentially regulated throughout follicle 
development, but their physiological roles remain unknown. Using conditional gene 
targeting, we found that granulosa cell-specific inactivation of Wnt5a (but not Wnt11) 
results in female infertility associated with increased follicular atresia and decreased rates 
of ovulation. Microarray analyses revealed WNT5a acts to down-regulate the expression 
of FSH-responsive genes in vitro, and corresponding increases in the expression of these 
genes were found in the granulosa cells of the conditional knockout mice. Unexpectedly, 
we found that WNT5a regulated its target genes not by signaling via the WNT/Ca2+ or 
planar cell polarity pathways, but rather by inhibiting the canonical pathway, causing both 
CTNNB1 and CREB protein levels to decrease via a GSK3β-dependent mechanism. We 
further found that WNT5a prevents FSH and LH from upregulating CTNNB1, CREB and 
their target genes, indicating that WNT5a functions as a physiological inhibitor of 
gonadotropin signaling. Together, these findings identify WNT5a as a key regulator of 
follicle development and gonadotropin responsiveness. 
Key words: Wnt5a, granulosa cells, gonadotropins 
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4.3 Introduction 
The pituitary gonadotropins follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH) represent the major endocrine regulators of ovarian function, and are 
essential for follicle development beyond the secondary stage (1, 2). In addition to the 
endocrine level of control, follicle development is also regulated by a number of paracrine 
and autocrine factors produced within the ovary itself. These factors notably include 
insulin-like growth factor-1, steroid hormones, prostaglandins, epidermal growth factor-
like molecules and several transforming growth factor-β superfamily members, all of 
which are indispensable for normal ovarian function and female fertility. Importantly, the 
gonadotropins can impact the expression and function of these intraovarian factors; 
conversely these factors can modulate follicular responses to the gonadotropins (1-3). 
Recent studies have established the WNT family of secreted glycoproteins as yet 
another class of signaling molecules that act to modulate and coordinate follicular 
responses to the gonadotropins, and whose activities are indispensable for ovarian 
function and female fertility.  During FSH-stimulated follicle growth, the WNT/CTNNB1 
signaling pathway (also known as the canonical pathway) appears to play a central role.  
Here, the binding of a WNT to a cognate frizzled (FZD) receptor results in the 
stabilization of the signaling effector CTNNB1 (β-catenin), which then translocates to the 
nucleus and associates with a number of transcription factors to alter the transcriptional 
activity of target genes (4-9). In granulosa cells, CTNNB1 was shown to bind the 
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transcription factor NR5A1 (steroidogenic factor-1), resulting in the up-regulation of 
Cyp19a1 (aromatase) expression in vitro (10). Further in vitro experiments using the 
Cre/LoxP system to knock down CTNNB1 expression in primary cultured granulosa cells 
confirmed its requirement for FSH-induced estrogen synthesis (11). The identity of the 
WNT signaling molecule that acts upstream of CTNNB1 in this context remains unclear. 
WNT2 is expressed in granulosa cells, has been shown to stimulate proliferation in vitro 
and signals via the CTNNB1 pathway (12-14), but its in vivo role has not yet been 
established. Likewise, WNT4 is required for antral follicle development, and its 
overexpression results in increased Cyp19a1 expression in vitro, however its conditional 
inactivation does not affect estrogen biosynthesis in vivo (7). Another possibility is that, in 
addition to (or perhaps instead of) by WNTs, the activation of CTNNB1 signaling in 
granulosa cells is caused by FSH itself. Indeed, FSH was found to induce the 
(ser552/ser665) phosphorylation of CTNNB1 in a PKA-dependent manner, resulting in an 
increase of Lhcgr transcriptional activity (15). Another recent study expanded upon the 
role of CTNNB1 during follicle growth using a transgenic mouse model in which 
CTNNB1 was constitutively activated in the granulosa cells of antral follicles (16). This 
resulted in a marked enhancement of FSH action, inducing an overexpression of FSH-
responsive genes including Cyp19a1, Nr5a1, Fshr and Ccnd2 and promoting follicle 
growth (16).  
Considerable progress has also been made in the elucidation of the roles of WNT 
signaling in LH-regulated processes. LH induces the expression of a number of WNT 
signaling effectors in both granulosa and cumulus cells, including WNT4, the receptors 
FZD1 and FZD4, as well as secreted frizzled-related protein-2 (SFRP2) and SFRP4 (17). 
The conditional inactivation of Wnt4 in granulosa cells in vivo blunts the induction of 
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genes involved in ovulation and steroidogenesis (Adamts1, Ptgs2, Star, Cyp11a1) in 
response to hCG/LH, and results in lower circulating progesterone levels (7). Female 
Fzd4-null mice are sterile at least in part due to abnormal development and function of the 
corpus luteum (CL), including decreased progesterone synthesis and altered morphology, 
gene expression and vasculogenesis (18). In addition, Fzd1-null mice are subfertile, and 
gene expression analyses of cumulus-oocyte complexes revealed a blunted response of 
both oocyte and cumulus genes to LH/hCG (19). As for FSH, LH may also activate 
CTNNB1 signaling independently of WNT/FZD. Using a bovine luteal cell model, Roy et 
al. observed that LH could induce the phosphorylation (and inactivation) of glycogen 
synthase kinase 3β (GSK3β) in a PKA-dependent manner. As phosphorylation of 
CTNNB1 by GSK3β normally causes its degradation, LH thereby stabilized CTNNB1, 
resulting in the transcriptional up-regulation of STAR and increased progesterone synthesis 
(20). 
WNTs are frequently categorized according to pathway(s) via which they signal.  
Certain WNTs, such as WNT1 and WNT3a, preferentially (or exclusively) activate the 
canonical pathway, whereas WNT5a and WNT11 are associated with non-canonical 
pathways in mammalian cells. The two best-characterized non-canonical pathways are the 
planar cell polarity (PCP) and WNT/Ca2+ pathways (21, 22). In the latter, the WNT-FZD 
complex interacts with heterotrimeric G proteins to activate phospholipase C (PLC), 
resulting in increased intracellular Ca2+ concentrations and the activation of Ca2+-
dependent effectors including protein kinase C (PKC), calmodulin-dependent kinase II 
(CAMKII) and calcineurin (23-26). In the PCP pathway, the WNT-FZD complex activates 
two parallel pathways involving the small GTPases RHO and RAC (27), which in turn 
activate disheveled associated activator of morphogenesis 1 (DAAM1), RHO-associated 
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kinase (ROCK) and cJUN kinase (JNK) (28-31). DAAM1, ROCK and JNK then act via 
different effectors mainly to modify the actin cytoskeleton, leading to cytoskeletal 
rearrangement (32). However, JNK-mediated phosphorylation of the transcription factor 
cJUN also occurs in certain contexts, resulting in the transcriptional activation of target 
genes (22, 33). 
Little is known of non-canonical WNT signaling in the ovary. Wnt5a and Wnt11 
are expressed in mouse granulosa cells (34), and Wnt5a transcripts have been detected in 
human luteinized granulosa cells and cumulus cells (35, 36). We have recently identified 
Wnt5a as gene whose expression is down-regulated by FSH, using a bovine primary 
granulosa cell culture model (37). We found that exogenous WNT5a suppressed FSH-
stimulated estradiol and progesterone secretion and CYP19A1 expression, but stimulated 
the expression of FOS and JUN by signaling via the PCP pathway. Although the 
physiological relevance of these findings is not clear, it was proposed that WNT5a may 
play a role in suppressing steroidogenesis during follicular atresia. The objectives of the 
present report were to determine the physiological roles of non-canonical WNTs in the 
mouse ovary, as well as their mechanisms of action. To this end, we used conditional 
targeting of WNT5a and WNT11 as a primary experimental approach. 
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4.4 Materials and methods 
Animal models, fertility trials, ovulation rate and follicle counting 
C57BL/6J mice (referred to herein as wild-type, WT) were obtained from the 
Jackson Laboratory (Bar Harbor, ME) and Wnt5atm1.1Homy (RBRC04609, hereafter 
Wnt5aflox) mice were obtained from RIKEN BRC (Tsukuba, Ibaraki, Japan). Genotyping 
analyses for the Wnt5a alleles were done by PCR using DNA from tail biopsies and the 
primers 5´- GTGAGGGACTGGAAGTTGCAGGA -3´, 5´-
CAACGGAAACATCCGAGGTCTCT -3´and 5´-
CCAGCCACTGGCTTTAGAGAAAGT -3´, using the following cycling conditions: 2 
min at 95º C for one cycle, 30 sec at 95º C, 30 sec at 68º C, and 30 sec at 72º C for 35 
cycles, and 7 min at 72º C for one cycle. Primers were designed to generate PCR products 
of 398 bp for the floxed allele, 335 bp for the Cre-recombined allele and 243 bp for the 
WT allele. Genotype analyses of Wnt11tm1.1Khay (38) (hereafter Wnt11flox), Amhr2tm3(cre)Bhr 
(39) (hereafter Amhr2cre) and Tg(CYP19A1-cre)1Jri (40) (hereafter CYP19-cre) mice were 
done as previously described. To assess female fertility, eight week-old females of 
experimental and control genotypes were housed with eight week-old WT males, and 
monitored daily for litters.  Litter sizes were recorded at birth.  Males were removed after 
6 months, and the experiment was terminated 22d later to allow for the final litter. To 
determine ovulation rates, 8-10 week-old females of experimental and control genotypes 
were housed with WT males and monitored daily for the presence of a vaginal plug.  
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Females were then sacrificed, the oviducts removed and placed in sterile saline under a 
dissection microscope. Cumulus-oocyte complexes were released by tearing open the 
ampullae of the oviducts with forceps, and counted. Follicle counting was done on 
formalin-fixed, paraffin embedded ovaries. In all cases, only the left ovary from each 
animal was analyzed.  Serial sections were prepared at a thickness of 5 μm and every 5th 
section was stained with hematoxylin and eosin.  Follicles in which the oocyte nucleus 
was visible were counted, classified according to Pedersen’s system and scored as healthy 
or atretic as previously described (7). All animal procedures were approved by the 
institutional animal care and use committee and conformed to the International Guiding 
Principles for Biomedical Research Involving Animals. 
 
Granulosa cell isolation and culture  
All materials were obtained from Life Technologies Inc. (Burlington, ON, Canada) 
unless otherwise stated. Ovaries were obtained from immature (21-26 day-old) mice 48 h 
after administration of equine chorionic gonadotropin (eCG, Folligon, Intervet, Kirkland, 
Québec, Canada, 5IU, IP) followed or not by human chorionic gonadotropin (hCG, 
Chorulon, Intervet, 5IU, IP) for 4-12 h. Granulosa cells (GCs) were isolated by placing the 
ovaries in Hanks balanced salt solution (HBSS) and puncturing with 26-gauge needles to 
release the GCs as previously described (41). 
GCs for primary culture were obtained from eCG-treated immature mice as 
described above and plated in 48-well culture plates (each well receiving the GCs isolated 
from approximately 0.7 ovary) in MEM containing 1% fetal bovine serum, 0.25 nM 
sodium pyruvate, and 3 mM L-glutamate, for 3 h at 37ºC with 5% CO2. Culture medium 
was then replaced with serum-free medium for 2h prior to addition of recombinant 
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WNT11 or WNT5a (R&D Systems, Minneapolis, MN). For some experiments, small 
molecule inhibitors (Tocris Bioscience, Bristol, United Kingdom) were added to the 
culture medium 1h prior to addition of WNT5a. These included SP600125 (cat # 1496, 
100 μm), NSC23766 (cat # 2161, 100μm), KN-93 (cat # 1278, 2.5 μm), Xestrospongin C 
(cat # 1280, 5 μm), GF109203X (cat # 0741, 30 μm), and SB216763 (cat # 1616, 1 μm). 
To study the effects of WNT5a on gonadotropin signaling, GCs were pretreated with 
WNT5a (3.5 μg/ml) for 1 hour prior to addition (or not) of recombinant human FSH or LH 
(50 ng/ml, National Hormone and Peptide Program, Torrance, CA). Either immediately 
after isolation or following culture, GCs were lysed with RLT buffer (Qiagen) or Laemmli 
loading buffer and stored at -80ºC prior to RNA extraction or SDS-PAGE.  
 
Real-time RT-PCR and microarray analyses 
Total RNA from granulosa cells was extracted using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. Reverse transcription was done using 200 ng of 
RNA and the SuperScript Vilo cDNA synthesis kit (Invitrogen). Real-time PCR was done 
using SsoAdvanced™ Universal SYBR® Green supermix (172-5274; Bio-Rad, 
Mississauga, Ontario, Canada) and a CFX96 Touch™ instrument (Bio-Rad). Each PCR 
reaction consisted of 7.5 μl of SsoAdvanced SYBR Green PCR Master Mix, 2.3 μl of 
water, 4 μl of cDNA sample, and 0.6 μl (10 pmol) of gene-specific primers (Supplemental 
Table 1). Cycling conditions were 3 min at 95º C followed by 40 cycles of 15 sec at 95º C, 
30 sec at 60º C, and 30 sec at 72º C. To quantify relative gene expression, the Ct of target 
gene amplification was normalized to the expression level of a housekeeping gene (Rpl19) 
according to the ratio, R= ECt Rpl19/ECt target, where E is the amplification efficiency for each 
primer pair.  
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 Microarray analyses were done in triplicate on RNA samples from cultured 
granulosa cells treated (or not) with 3.5 μg/ml recombinant WNT5a or WNT11 for 3h as 
described above, and using Agilent 8×60k Mouse Gene Expression Arrays (Agilent 
Technologies Inc., Mississauga, ON, Canada). All steps of RNA quality control, probe 
synthesis, hybridization, washing, and array scanning were performed by the McGill 
University (Genome Quebec) Innovation Center (Montreal, QC, Canada). Microarray data 
were analyzed using FlexArray 1.6.1 software (Genome Quebec). A P value threshold of 
0.05 and 2.0-fold change cutoff values were used for identification of differentially 
expressed genes (WNT5a- or WNT11-treated vs untreated control). Gene ontology and 
pathway analyses were conducted online using the Database for Annotation, Visualization 
and Integrated Discovery (DAVID), v6.7 (NIAID, NIH). 
 
Immunohistochemistry 
Paraformaldehyde-fixed, paraffin-embedded ovaries were sectioned at a thickness 
of 4μm. Immunohistochemical analysis was done using an anti-cleaved caspase 3 
antibody (9661S; Cell Signaling Technology) incubated at a 1:100 dilution overnight at 
4°C.  Subsequent detection steps were done using the Vectastain Elite ABC kit and the 
3,3´ diaminobenzidine peroxidase substrate kit (Vector Laboratories, Burlingame, CA) as 
previously described (42). Slides were lightly counterstained with hematoxylin prior to 
mounting. 
 
Immunoblotting 
Immunoblotting was done as previously described (43) using primary antibodies 
against non-phosphorylated (Ser33/37/Thr41) (i.e., active) CTNNB1 (catalog # 8814), 
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phospho (Ser552) CTNNB1 (# 9566s), total CTNNB1 (# 8480), phospho-CREB (# 9191), 
total CREB (# 9197), phospho-AKT (# 4060), total AKT (# 4691), phospho-JNK (# 
9251), total JNK (# 9252), phospho-JUN (# 2361, 1:500), total JUN (# 9165, 1:500), 
phospho-CAMKΙΙ (# 3361), total CAMKΙΙ (# 4436), phospho-GSK3β (# 9323), total 
GSK3β (# 12456), phospho-CAPZIP (# 07-2190, Millipore, Billerica, MA) CAPZIP (# 
07-2189, 1:250, Millipore) or ACTB (# sc-47778, 1:10000, Santa Cruz Biotechnology, 
Dallas, TX) diluted in 5% bovine serum albumin. All antibodies mentioned above were 
obtained from Cell Signaling Technology (Danvers, MA) and used at a 1:1000 dilution 
unless otherwise specified. After washing three times with TTBS, membranes were 
incubated for 1 h at room temperature with anti-rabbit HRP-conjugated IgG (GE 
Healthcare Life Sciences, Baie d’Urfé, Canada) diluted 1:10000 in 5% non-fat dry milk in 
TTBS. In some instances, membranes were sequentially stripped and re-probed with 
several antibodies. Protein bands were visualized by chemiluminescence (ECL, Millipore) 
and quantified using a ChemiDoc MP detection system (Bio-Rad) and Image Lab™ 
software.  
 
Steroid Hormone Measurement 
Blood samples were collected by cardiac puncture prior to euthanasia. Estradiol (E2) 
and progesterone (P4) levels in the serum were determined by ELISA and 
radioimmunoassay, respectively. All assays were performed by the Ligand Assay and 
Analysis Core Laboratory of the University of Virginia (Charlottesville, VA). 
 
Statistical Analyses 
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All statistical analyses were performed using Prism 4.0a (GraphPad Software Inc., 
La Jolla, CA) software. All the data sets (ovary weights, follicle numbers, mRNA 
expression, protein expression, and steroid hormone levels) were subjected to the F-test to 
determine equality of variances. Data were transformed to logarithms if they were not 
normally distributed. Two-tailed t-tests were used when two experimental groups were 
compared, or ANOVA (with Tukey’s multiple comparisons post-test) to compare three or 
more groups. All data are presented as means ± SEM. 
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4.5 Results 
Wnt5a expression in granulosa cells is required for normal female fertility. 
To study Wnt5a and Wnt11 expression in granulosa cells and their regulation by 
gonadotropins in vivo, immature mice were treated with (FSH-mimetic) eCG for 48h to 
stimulate follicle growth, followed by (LH-mimetic) hCG to provoke 
ovulation/luteinization (ovulation occurs 12-14h post-hCG in this model). Results showed 
a gradual increase in Wnt5a mRNA levels throughout follicle development that reached 
statistical significance near the time of ovulation (Fig. 1). Conversely, eCG did not affect 
Wnt11 expression, but hCG induced a transient increase in Wnt11 mRNA that returned to 
basal levels by the time of ovulation. These results indicate that Wnt5a and Wnt11 are 
differentially regulated by gonadotropins during follicle development. 
 To study the physiological functions of Wnt5a and Wnt11 in granulosa cells, we 
generated conditional knockout (cKO) mice by mating strains bearing floxed alleles to 
both the CYP19-cre and Amhr2cre strains. This strategy was designed to target distinct 
stages of follicle development, as the Amhr2cre knock-in allele drives Cre activity in 
granulosa cells mainly from the secondary stage onwards (39), whereas the CYP19-Cre 
transgene drives Cre expression from the antral stage (40). RT-qPCR analyses of 
granulosa cells from eCG-treated immature mice showed a significant (P<0.05), ~4-6 fold 
reduction in Wnt5a and Wnt11 mRNA levels in corresponding cKO mice relative to 
controls, using either the Amhr2cre or the CYP19-Cre strains (Figs. 2 and S1). No 
compensatory overexpression of Wnt11 was observed in the Wnt5a cKO model, or vice-
versa.  Six-month mating trials were then done to study the effects of Wnt5a and Wnt11 
loss on female fertility. Conditional inactivation of Wnt5a using the Amhr2cre strain 
resulted in a ~52% decrease in average litter sizes, and ~20% when using the CYP19-Cre 
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(P<0.05, Tables 1 and S2). Conversely, loss of Wnt11 did not result in a loss of fertility 
with either Cre driver, and the concomitant inactivation of Wnt5a and Wnt11 did not result 
in a greater loss of fertility than the inactivation of Wnt5a alone (Tables S3, S4, S5). These 
results indicate that Wnt5a expression in granulosa cells is required for normal female 
fertility, and that its loss at the preantral stage (i.e., driven by the Amhr2cre) results in a 
more severe phenotype than when it is lost at later stages. Wnt11 on the other hand 
appears dispensable for female fertility, and its expression in granulosa cells cannot 
compensate for the loss of Wnt5a. 
 
Wnt5aflox/-;Amhr2cre/+ mice have defects in follicle development and ovulation  
Histopathological examination of the ovaries and reproductive tracts were conducted in 
adult mice for all cKO models. No morphological defects were detected in the ovaries, 
uteri or oviducts of any genotype, except in the Wnt5aflox/-;Amhr2cre/+ and Wnt5aflox/-
;Wnt11flox/-;Amhr2cre/+ females, in which the ovaries appeared smaller and to have reduced 
numbers of antral follicles and corpora lutea (Fig. 3 and not shown). Wnt5aflox/-;Amhr2cre/+ 
mice (but none of the others) also had reduced ovary weights compared to controls 
(P<0.05, Table 2 and not shown).   
 To provide a quantitative analysis of folliculogenesis, follicle counting was done 
using serial histologic sections of ovaries from Wnt5aflox/-;Amhr2cre/+ mice at various ages. 
Five day-old Wnt5aflox/-;Amhr2cre/+ mice had normal numbers of primordial and primary 
follicles, indicative of a normal ovarian reserve and postnatal follicle formation (Fig. 4A). 
However, at 42d of age, numbers of primordial, healthy secondary and healthy antral 
follicles were decreased to 46%, 44% and 28% of controls, respectively (P<0.05) (Fig. 
4B). Similar reductions in numbers of healthy secondary and antral follicles were 
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observed at 8 months of age, but numbers of primordial follicles further decreased to 20% 
of controls, and primary follicles were also significantly reduced (P<0.05, Fig. 4C). At 
42d of age, fully 78% of antral follicles were atretic in the Wnt5aflox/-;Amhr2cre/+ group, 
versus 36% in controls. Increased atresia was also evidenced by activated caspase-3 
immunohistochemistry, which showed a vastly greater incidence of granulosa cell 
apoptosis in secondary and antral follicles in ovaries from Wnt5aflox/-;Amhr2cre/+ mice (Fig. 
3B). 
 Based on these results, we suspected that the infertility of Wnt5aflox/-;Amhr2cre/+ mice 
was due to the decrease in healthy antral follicle numbers, leading to a reduction in the 
number of ovulations occurring per cycle. To verify this, Wnt5aflox/-;Amhr2cre/+ females 
were sacrificed after mating and cumulus-oocyte complexes (COCs) retrieved from the 
oviducts and counted.  Results showed a 59% decrease in recovered COCs in Wnt5aflox/-
;Amhr2cre/+ females compared to controls (P<0.05, Table 3). Infertility in these mice was 
therefore attributed mainly to a reduction in the numbers of follicles attaining the 
ovulatory stage. 
 
WNT5a down-regulates the expression of FSH-responsive genes 
To determine the mechanism of action of WNT5a, we first aimed to identify its 
transcriptional targets. Granulosa cells from eCG-primed immature mice were placed in 
culture and treated (or not) with recombinant WNT5a or WNT11, and global changes in 
gene expression analyzed by microarray. WNT5a treatment increased the expression of 
542 genes and decreased the expression of 1656 genes by at least 2-fold over control 
(Supplemental data, WNT5a microarray results Excel file 1). Conventional in silico gene 
ontology and pathway analyses failed to detect a significant association between the 
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putative WNT5a target genes and specific signaling pathways or biological 
functions/processes (not shown). Nonetheless, we observed that many of the genes most 
highly down-regulated by WNT5a were key FSH-responsive genes associated with 
granulosa cell steroidogenesis, differentiation and proliferation. The regulation of a subset 
of these by WNT5a was confirmed by RT-qPCR (Figure 5). The expression of many of 
these FSH-responsive genes was also found to be increased in granulosa cells from eCG-
treated Wnt5aflox/-;Amhr2cre/+ mice (Fig. 6), confirming them as bona fide targets of 
WNT5a signaling in vivo. The increase in Cyp19a1 expression was also accompanied by 
increased serum estradiol levels in these mice, as well as decreased progesterone levels 
(Table 4). 
 Unlike WNT5a, microarray analyses revealed a very small number of genes that 
were regulated by WNT11 in vitro; 51 and 22 genes were respectively up- or down-
regulated at least two fold (Supplemental data, WNT11 microarray results Excel file 2). 
Only one gene, Il1b, was up-regulated by both WNT5a and WNT11 (Fig. 7). To further 
study potential functional redundancy between WNT5a and WNT11, granulosa cells were 
treated with graded doses of WNT11, and its effects on the mRNA levels of WNT5a 
target genes were determined by RT-qPCR. Although WNT11 was also able to down-
regulate WNT5a target genes to some extent, it was generally much less potent than 
WNT5a itself (Fig. 7). Accordingly, the expression of WNT5a target genes was not 
changed in granulosa cells from eCG-treated Wnt11aflox/-;Amhr2cre/+ mice, nor were they 
further up-regulated in the granulosa cells of Wnt5aflox/-;Wnt11aflox/-;Amhr2cre/+ relative to 
Wnt5aflox/-;Amhr2cre/+ mice (Fig. S2). WNT11 may therefore be able to signal via similar 
mechanisms as WNT5a, but does not seem to function in a redundant manner with 
WNT5a in the physiological context. 
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WNT5a suppresses the canonical pathway in granulosa cells 
To determine the intracellular signaling mechanisms whereby WNT5a regulates its 
target genes, mouse granulosa cell primary cultures were treated with WNT5a on a time 
course, and the expression of mediators of the PCP signaling pathway was assessed. 
WNT5a did not affect JNK or cJUN expression or phosphorylation (Fig. S3). 
Phosphorylation of CAPZIP, another substrate of JNK, was similarly unaffected (Fig. S3). 
mRNA levels of cJUN transcriptional targets genes such as Fos and Jun did not change in 
response to WNT5a (Fig. 5), nor were they altered in the granulosa cells of Wnt5aflox/-
;Amhr2cre/+ mice (Fig. 6). Furthermore, pretreatment of granulosa cells with the JNK 
inhibitor SP600125 or the RAC1 inhibitor NSC23766 did not prevent WNT5a from down-
regulating the expression of its target genes (Fig. S4). Similar experiments were conducted 
to determine the effects of WNT5a on WNT/Ca2+ pathway activity. WNT5a did not affect 
the expression or phosphorylation of CAMKII (Fig. S3). Likewise, pretreatment of 
granulosa cells with the PKC inhibitor GF109203X, the CAMKII inhibitor KN-93 or with 
Xestrospongin C (which prevents Ca2+ release by blocking the IP3 receptor) had no effect 
on the ability of WNT5a to downregulate its target genes, although basal levels of 
Cyp19a1 expression were affected in some cases (Fig. S4). Together, these results suggest 
that neither the PCP nor the WNT/Ca2+ pathway is a major mediator of WNT5a signaling 
in this model. 
 Beyond the activation of non-canonical signaling pathways, non-canonical WNTs 
are also known to suppress the canonical WNT pathway in certain contexts (26, 44-48). 
We therefore did a time course analysis of the effects of WNT5a on the expression of non-
phosphorylated (Ser33/Ser37/Thr41)(i.e., active) CTNNB1 and total CTNNB1. The 
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expression of both forms showed a rapid and dramatic decrease in response to WNT5a 
(Fig. 8). Destabilization of CTNNB1 can be induced by phosphorylation at its N-terminus 
by GSK3β (15, 49, 50), and/or by loss of phosphorylation at the C-terminus 
(ser552/ser665) (15, 51-53). Although levels of phospho (Ser552) CTNNB1 decreased in 
response to WNT5a, the ratio of phospho (Ser552) CTNNB1:total CTNNB1 remained 
unchanged, suggesting that C-terminal phosphorylation was not affected (Fig. 8).  
Conversely, pretreatment of granulosa cells with the GSK3 inhibitor SB216763 prevented 
WNT5a from decreasing CTNNB1 expression (Fig. 9), suggesting that WNT5a 
destabilizes CTNNB1 via a GSK3-dependent mechanism. However, this mechanism did 
not involve a rapid WNT5a-induced alteration in the expression of either total or phospho 
(Ser9) GSK3β (Fig. 8). 
 
WNT5a down-regulates CREB expression and inhibits gonadotropin responsiveness  
As for CTNNB1, the transcription factor CREB is both a critical mediator of 
gonadotropin signaling and a substrate for GSK3β, and is degraded subsequent to GSK3β-
mediated phosphorylation in certain contexts (51, 54-56). We therefore studied the effects 
of WNT5a on CREB expression in granulosa cells, and found that WNT5a down-
regulated CREB protein levels in a manner similar to CTNNB1 (Fig. 8). Pretreatment with 
SB216763 prevented this effect, indicating that it is GSK3-dependent (Fig. 9).   
 As WNT5a was found to down-regulate FSH-responsive genes (Fig. 5) and 
destabilized CTNNB1 and CREB, both of which are key mediators of FSH and LH 
signaling (Figs 8, 9) (2, 10, 16), we hypothesized that WNT5a functions to antagonize 
gonadotropin responsiveness in granulosa cells. To test this, granulosa cells were 
pretreated (or not) with WNT5a for 1h prior to addition of FSH or LH, and the expression 
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of CTNNB1 and CREB and mRNA levels of key FSH and LH target genes were 
determined. Both FSH and LH induced an increase in total, active and phospho (ser552) 
CTNNB1 protein levels in cultured granulosa cells, and WNT5a vastly decreased both 
basal and gonadotropin-stimulated expression of all three forms (Fig. 10A). As previously 
reported (57), both FSH and LH also increased the levels of total and (Ser133) 
phosphorylated CREB. As for CTNNB1, WNT5a pretreatment drastically downregulated 
CREB expression in both untreated and gonadotropin-treated granulosa cells (Fig. 10A). 
WNT5a pretreatment also inhibited (or abrogated) the ability of both FSH and LH to 
increase the mRNA levels of their target genes (Fig. 10B). Importantly, the mRNA levels 
of the same LH target genes were increased in the granulosa cells of Wnt5aflox/-;Amhr2cre/+ 
mice specifically 12h post-hCG treatment (Fig. 6), indicating that WNT5a also 
antagonizes LH action in vivo. Together, these results indicate that WNT5a functions as a 
physiological antagonist of gonadotropin signaling. 
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4.6 Discussion 
Whereas the gonadotropins are essential endocrine regulators of ovarian follicle 
development, their actions are dependent on a number of locally-produced ovarian factors 
that serve to modulate their effects. In this study, we identified WNT5a as a novel secreted 
regulatory molecule that acts to antagonize the follicular response to gonadotropins, based 
on our key findings that WNT5a prevented FSH and LH from inducing their 
transcriptional target genes in vitro, while an enhanced transcriptional response of these 
same targets to eCG/hCG was observed in Wnt5a cKO mice in vivo. Wnt5a may therefore 
function to prevent premature or excessive growth, limit steroid hormone synthesis, 
prevent premature luteinization, and otherwise temper the effects of FSH and LH as 
required to ensure the proper development of the follicle. 
 Our inability to detect activation of non-canonical signaling by WNT5a in murine 
granulosa cells was unexpected, particularly considering that we have recently reported 
that WNT5a signals via a RAC1/JNK/JUN pathway in cultured bovine granulosa cells 
(37). Although the basis for this discrepancy remains unknown, the culture systems used 
differed between the two studies. Notably, the bovine cells were cultured from early antral 
follicles, whereas the murine cells were cultured from the preovulatory follicles of eCG-
primed immature animals. As the WNT receptor complexes and signaling machinery 
present in granulosa cells may vary considerably from one phase of follicle development 
to the next, the differences between the studies may indicate that WNT5a signals via 
different mechanisms (and hence may have different physiological functions) at specific 
stages of folliculogenesis. Consistent with this, we found that the follicle development 
phenotype of the Wnt5aflox/-;Amhr2cre/+ model (in which secondary follicles are targeted) 
was much more severe than that of the Wnt5aflox/-;Amhr2cre/+;CYP19-Cre model (in which 
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only antral stages are targeted), suggesting specific functions for WNT5a at the secondary 
stage of development. Further studies will be required to properly dissect the stage-
specific roles and signaling mechanisms of WNT5a in granulosa cells. 
 Several mechanisms have been proposed to explain how non-canonical WNTs may 
act to decrease CTNNB1 levels. For instance, non-canonical WNTs have been shown to 
directly compete with canonical WNTs for binding to FZD receptor complexes, thereby 
attenuating the canonical CTNNB1 stabilization signal (44). WNT5a has been shown to 
increase the expression of SIAH ubiquitin ligase, resulting in the accelerated 
ubiquitination and degradation of CTNNB1 (45). WNT11 can also activate caspases that 
degrade CTNNB1 via an unknown mechanism (47). Although the mechanism whereby 
WNT5a causes CTNNB1 protein levels to decrease in granulosa cells was not determined 
in this study, we believe that the very rapid (i.e., minutes) nature of this effect suggests 
that competition with canonical WNTs for their receptor(s) is likely. Indeed, granulosa 
cells express several canonical WNTs (including WNT2 and WNT3a (58, 59)) and high 
levels of active CTNNB1, suggesting that a constitutive level of canonical WNT signaling 
normally occurs in the granulosa cells of growing follicles (see model, Fig. 11). Our data 
and previous studies suggest that FSH (and LH) signaling via PKA can enhance this 
CTNNB1 signaling in at least three ways. First, PKA can phosphorylate (and thereby 
inhibit) GSK3β, preventing it from promoting the degradation of CTNNB1 (52, 60). PKA 
can also directly phosphorylate CTNNB1 at ser552/ser665, enhancing its stability and 
transactivation activity (15). Finally, PKA also phosphorylates CREB, which then binds 
cAMP response elements present in the promoters of many of the CTNNB1 target genes 
identified in the current study (4, 52). Interestingly, CREB binding protein (CBP) has been 
shown to enhance the transcriptional properties of CTNNB1 in several cell types (16, 61, 
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62), suggesting an additional level of synergy between gonadotropin/PKA and canonical 
WNT signaling (Fig. 11). We propose that WNT5a disrupts these signaling processes by 
competing with canonical WNT(s) for their receptor(s). This results in the dissociation of 
the CTNNB1 destruction complex from the receptor complex and the activation of 
GSK3β, possibly due to the loss of an inhibitory interaction between GSK3β and the 
WNT co-receptor low-density lipoprotein receptor-related protein 5/6 (LRP5/6) (63). 
GSK3β then phosphorylates CTNNB1 and CREB, resulting in the proteosomal 
degradation of both, and effectively disrupting both the gonadotropin/PKA and canonical 
WNT pathways (Fig. 11). Gonadotropin signaling may therefore be regulated by the 
precise balance between WNT5a and canonical WNTs present within the follicular 
microenvironment. 
 The conditional knockout of Wnt5a in granulosa cells enhanced FSH signaling and 
resulted in an increase in the expression of FSH-responsive genes, many of which serve to 
promote follicle growth and survival. Despite this, a marked increase in follicular atresia 
occurred in the Wnt5aflox/-;Amhr2cre/+ model, causing a decreased ovulation rate and 
infertility, and leading to an accelerated depletion of the follicular reserve. Although we 
were unable to reconcile these apparently paradoxical findings, several explanations can 
be proposed. For instance, increased FSH responsiveness, estradiol synthesis and 
proliferation in granulosa cells may result in a loss of coordination of follicle development 
between the granulosa cells, theca cells and oocyte, ultimately compromising the viability 
of the follicle. Another possibility is that WNT5a produced in granulosa cells may be 
important for oocyte development, an idea that is supported by a recent study indicating 
that WNT5a plays a role in oocyte entry into meiosis during embryonic development (64). 
As suggested above, another possibility is that WNT5a plays roles during the secondary 
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(and/or earlier) stage(s) of follicle development that were not elucidated in our 
mechanistic studies. Indeed, our in vitro studies were conducted using gonadotropin-
treated mice and were focused on late stages of follicle development; a mechanism of 
WNT5a action occurring specifically at the secondary stage would therefore have been 
overlooked in our study design. If this were true, increased atresia in the Wnt5aflox/-
;Amhr2cre/+ model would be the result of a loss of WNT5a function other than its ability to 
suppress of CTNNB1 and gonadotropin signaling in growing follicles. Further studies will 
be required to test these ideas. 
 In summary, we report for the first time the crucial role of WNT5a in follicle 
development and normal female fertility. We found that WNT5a acts to suppress 
gonadotropin signaling by antagonizing the canonical WNT signaling pathway, thereby 
causing the degradation of CTNNB1 and CREB, two key transcriptional regulators of 
gonadotropin-responsive genes. This work provides new insight into the role of the non-
canonical WNTs in granulosa cells, and elucidates new signaling mechanisms that 
modulate gonadotropin action. 
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4. 9 Figures  
Figure 1. 
 
Figure 1. In vivo regulation of Wnt5a and Wnt11 mRNA levels in granulosa cells by 
gonadotropins.  
Immature (21-26 day-old) female mice were injected with eCG (5IU, IP) 44-48h prior to 
the administration of hCG. Granulosa cells were isolated by needle puncture. mRNA 
levels were determined by RT-qPCR and normalized to the housekeeping gene Rpl19. n=4 
animals per time point. Columns = means, error bars = SEM, columns lacking common 
letters are significantly different (P<0.05). 
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Figure 2. 
 
Figure 2.  Wnt5a and Wnt11 knockdown efficiency in the conditional knockout models.   
Expression of Wnt5a and Wnt11 was determined by RT-qPCR in granulosa cells isolated 
from immature, eCG treated mice of the indicated genotypes. Expression of each 
transcript was normalized to the housekeeping gene Rpl19. Control = corresponding 
genotype lacking the Amhr2cre allele. Values for each experimental genotype are 
expressed relative to their corresponding control. n=4 animals per genotype, columns = 
means, error bars = SEM, * = values are statistically different (P<0.05), ** = values are 
statistically different (P<0.01). 
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Figure 3. 
 
 
Figure 3. Wnt5aflox/-;Amhr2cre/+ mice have smaller ovaries and increased follicular atresia. 
A) Representative images of Wnt5aflox/-;Amhr2cre/+ (control) and Wnt5aflox/-;Amhr2cre/+ 
(mutant) ovaries from 42d-old animals. B) Activated caspase-3 immunohistochemistry 
done on ovaries from 6wk-old mice of the indicated genotypes. Negative control = control 
reaction in which the primary antibody was omitted. 
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Figure 4. 
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Figure 4. Progressive follicle loss and increased follicular atresia in the ovaries of 
Wnt5aflox/-;Amhr2cre/+ mice. Ovaries (n=6 per genotype at each age) were serially 
sectioned, and all follicles from every fifth section were counted, categorized as 
primordial, primary, secondary or antral, and scored as either healthy or atretic. Data 
represent raw follicle count numbers and were not adjusted to estimate the total ovarian 
follicle population. Columns = means, error bars = SEM, columns labeled with different 
letters are significantly different (P<0.05). 
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Figure 5. 
 
 
Figure 5. Quantitative RT-qPCR confirmation of microarray data. Primary cultured 
granulosa cells were treated or not with WNT5a (3.5μg/ml, 3h, n=4 samples/group), and 
mRNA levels of the indicated genes were determined by RT-qPCR and normalized to the 
housekeeping gene Rpl19. Columns = means, error bars = SEM, asterisks indicate a 
statistically significant (**: P<0.01, ***: P<0.001) effect of WNT5a treatment. 
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Figure 6. 
 
Figure 6. Expression of WNT5a target genes is altered in Wnt5aflox/-;Amhr2cre/+ mice. 
RT-qPCR analysis of the indicated genes was done on granulosa cell samples collected 
from immature mice of the indicated genotypes either immediately after eCG treatment 
(48h) or following an additional 12h treatment with hCG (n=4 animal/time point). All data 
were normalized to the housekeeping gene Rpl19. Columns = means, error bars = SEM, 
asterisks indicate a statistically significant (*: P<0.05, **: P<0.01, ***: P<0.001) 
difference vs control. 
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Figure 7. 
 
 
Figure 7.  Regulation of WNT5a target genes by WNT11.  
Primary cultured granulosa cells were treated or not with WNT11 or WNT5a at the 
indicated concentrations for 3h (n=4 samples/group), and mRNA levels of the indicated 
genes were determined by RT-qPCR and normalized to the housekeeping gene Rpl19. 
Columns = means, error bars = SEM, columns labeled with different letters are 
significantly different (P<0.05). 
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Figure 8. 
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Figure 8. WNT5a downregulates canonical WNT signaling and CREB expression in 
granulosa cells in vitro.  
Primary cultured granulosa cells were treated or not with WNT5a (3.5 μg/ml) for the 
indicated times, and the expression of the indicated proteins and phosphoproteins was 
studied by immunoblotting. Representative immunoblots showing 2 samples/treatment 
and time are shown in the upper panels, quantitative analyses of 4 samples/treatment and 
time are shown in the graphs. Columns = means, error bars = SEM, asterisks indicate a 
statistically significant (*: P<0.05, **: P<0.01, ***: P<0.001) effect of WNT5a treatment.  
Values for the WNT5a treated groups are expressed relative to their corresponding 
controls at each time point. 
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Figure 9. 
 
Figure 9.  WNT5a downregulation of CTNNB1 and CREB is GSK3β-dependent.  Primary 
cultured granulosa cells were treated with WNT5a (3.5 μg/ml) for 15 minutes, with or 
without pretreatment with SB216763 (1μM, 1h), and the expression of CTNNB1 and 
CREB was studied by immunoblotting (n = 3 samples/treatment). Immunoblots are shown 
in the upper panels, quantitative analyses of which are shown in the graphs.  Columns = 
means, error bars = SEM, columns labeled with different letters are significantly different 
(P<0.05). 
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Figure 10.  
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Figure 10. WNT5a suppresses gonadotropin signaling in granulosa cells.  
A) Primary cultured granulosa cells were treated or not with LH or FSH (50 ng/ml, 1h), 
with or without pretreatment with WNT5a (3.5μM, 1h) and the expression of the indicated 
proteins and phosphoproteins was studied by immunoblotting. Representative 
immunoblots showing 2 samples/treatment and time are shown in the upper panels, 
quantitative analyses of 4 samples/treatment and time are shown in the graphs. B) Primary 
cultured granulosa cells were treated or not with LH or FSH (50 ng/ml, 2h), with or 
without pretreatment with WNT5a (3.5μM, 1h) and the mRNA levels of the indicated 
FSH and LH target genes were studied by RT-qPCR. Expression of each transcript was 
normalized to the housekeeping gene Rpl19, n = 4 samples/treatment. Columns = means, 
error bars = SEM, columns labeled with different letters are significantly different 
(P<0.05).   
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Figure 11. 
 
 
Figure 11. Working model of the mechanism of action of WNT5a in granulosa cells.  
Left: canonical WNTs act in tandem with gonadotropin/PKA signaling in the granulosa 
cells of growing follicles to stabilize CTNNB1 and CREB, resulting in the transcriptional 
activation of CTNNB1 and FSH/LH target genes. Right: WNT5a may antagonize 
canonical WNTs by competing for their receptor complex.  The resultant disinhibition of 
GSK3β leads to the degradation of CTNNB1 and CREB, thereby antagonizing 
gonadotropin action. 
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4.10 Supplemental figures 
Figure S1. 
 
 
Figure S1. Wnt5a and Wnt11 knockdown efficiency in the conditional knockout models.   
Expression of Wnt5a and Wnt11 was determined by RT-qPCR in granulosa cells isolated 
from immature, eCG treated mice of the indicated genotypes. Expression of each 
transcript was normalized to the housekeeping gene Rpl19. Control = corresponding 
genotype lacking the CYP19-cre transgene. Values for each experimental genotype are 
expressed relative to their corresponding control. n=4 animals per genotype, columns = 
means, error bars = SEM, * = values are statistically different (P<0.05), ** = values are  
statistically different (P<0.01). 
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Figure S2. 
 
 
Figure S2. Expression of WNT5a target genes in Wnt11flox/-;Amhr2cre/+ and Wnt5aflox/-
;Wnt11flox/-;Amhr2cre/+mice.   
RT-qPCR analysis of the indicated genes was done on granulosa cell samples collected 
from immature mice 48h after eCG treatment (n=4 animals/genotype). All data were 
normalized to the housekeeping gene Rpl19. Control = corresponding genotype lacking 
the Amhr2cre allele. Columns = means, error bars = SEM, asterisks indicate a statistically 
significant (*: P<0.05, **: P<0.01) difference vs control. 
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Figure S3. 
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Figure S3. WNT5a does not regulate non-canonical signaling effectors in granulosa cells. 
Primary cultured granulosa cells were treated or not with WNT5a (3.5 μg/ml) for the 
indicated times, and the expression of the indicated proteins and phosphoproteins was 
studied by immunoblotting.  Representative immunoblots showing 2 samples/treatment 
and time are shown in the upper panels, quantitative analyses of 4 samples/treatment and 
time are shown in the graphs. Columns = means, error bars = SEM, values for the WNT5a 
treated groups are expressed relative to their corresponding controls at each time point. 
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Figure S4. 
 
 
Figure S4. Inhibition of noncanonical signaling does not prevent WNT5a-mediated 
suppression of its target genes.  
Primary cultured granulosa cells were treated with WNT5a (3.5 μg/ml) for 15 minutes, 
with or without pretreatment with the inhibitors SP600125 (SP6), NSC23766 (NSC), 
GF109203X (GF), KN-93 (KN) or Xestrospongin C (Xes), and the mRNA levels of the 
indicated WNT5a target genes were studied by RT-qPCR. Expression of each transcript 
was normalized to the housekeeping gene Rpl19, n = 4 samples/treatment. Columns = 
means, error bars = SEM, asterisks (*) indicate a statistically significant difference vs 
control, P < 0.05. 
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4.11 Tables  
 
Table  1. Mating trials 
Variable Amhr2cre/+ Wnt5aflox/- Wnt5aflox/-;Amhr2cre/+
Female 6 6 6 
Total litters 38 34 24 
Total pups 278 282 96 
Litter size 7.32±0.30a 8.29±0.32a 4.00±0.38b 
Values are means ± SEM. 
Values without common superscripts are significantly different (P<0.05). 
 
 
Table  2. Ovary weights     
Variable  Wnt5aflox/- Wnt5aflox/-;Amhr2cre/+ 
Immature +eCG      
N  12 12 
Weight (mg) 5.53±0.22a 3.83±0.24b 
Adult  
N 12 14 
Weight (mg) 5.38±0.22a 4.18±0.22b 
Values are means ± SEM. 
Values without common superscripts are significantly different (P<0.05). 
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Table  3. Ovulatory rates 
Variable Wnt5aflox/- Wnt5aflox/-;Amhr2cre/+ 
Number 4 4 
Total COCs 37 15 
Litter size 9.25±0.62a 3.75±1.93b 
COCs: Cumulus oocyte complexes 
Values are means ± SEM. 
Values without common superscripts are significantly different (P<0.05). 
 
 
 
Table 4. Hormone assays     
Variable  Wnt5aflox/- Wnt5aflox/-;Amhr2cre/+ 
Immature +eCG (number) 
N 4 4 
E2 (pg/ml) 76.08±18.32a 197.20±40.79b 
P4 (ng/ml) 9.55±2.14a 1.83±0.25b 
Values are means ± SEM. 
Values without common superscripts are significantly different (P<0.05). 
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4.12 Supplemental Tables 
Table S1. Primer sequences 
 
  Forward primer (5´- 3´) Reverse primer (5´- 3´) 
Areg CTCGCAGCTATTGGCATCGGCA TGGCATGCACAGTCCCGTTT 
Axin2 CCACTTCAAGGAGCAGCTCAGCA TACCCAGGCTCCTGGAGACTGA 
Btc CTTGCCCTGGGTCTTGCAAT GAGGGAGTTTGCTCGTCCAC 
Cyp11a1 GTGACCTTGCAGAGGTACACTGT GTGACTCCAGCCTTCAGTTCACA 
Cyp19a1 CTGAACATCGGAAGAATGCACAG GAGTAGATAGGCCACACTTCTTC 
Ereg ACGTTGCGTTGACAGTGATTCTCAT GGTCCCCTGAGGTCACTCTCTCAT 
Esr1 CGTGTGCAATGACTATGCCTCT TGGTGCATTGGTTTGTAGCTGG 
Esr2 GTCAGGCACATCAGTAACAAGGG ATTCAGCATCTCCAGCAGCAGGTC 
Fos AGCCAAGTGCCGGAATCGGA AGGTCGGTGGGCTGCCAAAA 
Fshr TGGATGTCATCACTGGCTGTGTCA ATTCTGGAAGGCCTCAGGGTTGAT 
Grem1 CTGGAGACCCAGAGTACCGT TGCGATTCATTCTGTCACTTCC 
Il1b TAGGCTCATCTGGGATCCTCT TCATTCTCATCACTGTCAAAAGGTG 
Inhbb AGATCATCAGCTTTGCAGAGACA GCCTGCACCACGAATAGGTT 
Jun AACCGCATTGCCGCCTCCAA TCCCTGAGCATGTTGGCCGT 
Lhcgr AGATGCACAGTGGCACCTTCCAG ATGACGTGGCGATGAGCGTCT 
Nr5a1 ACCTGGCGGTAGATGTGGTCCAA TGTCGACTGGGCACGAAGGT 
Prlr ATACTGGAGTAGATGGGGCCAGGAG CTTCCATGACCAGAGTCACTGTCAGGAT 
Pten GCCAAATTTAACTGCAGAGTTGC ACAGTGAATTGCTGCAACATGA 
Ptgs2 TCCCCTTCCTGCGAAGTTTA TAGAAGAACCTTTTCCAGCACTTC 
Star GATTAAGGCACCAAGCTGTGCTG CTGCTGGCTTTCCTTCTTCCAGC 
 
WNT5a 
 
GTCTTCCAAGTTCTTCCTAATGGCT CCAGGTTGTTATAGAAGCTAACTTG 
Wnt11 GAGGCTGTGCTCTTTGCC CTGCCGGAGTCTTGGACAGT 
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Table S2. Mating trials 
Variable Cyp19 Wnt5aflox/flox  Wnt5aflox/flox;Cyp19-Cre 
Female 5 6 6 
Total litters 30 36 33 
Total pups 219 257 189 
Litter size 7.31±0.48a 7.13±0.42a 5.73±0.36b 
Values are means ± SEM. 
Values without common superscripts are significantly different (P<0.05). 
 
 
 
Variable Wnt11flox/- Wnt11flox/-;Amhr2cre/+  
Female 5 6 
Total litters 28 33 
Total pups 199 247 
Litter size 7.11±0.24 7.48±0.49 
Values are means ± SEM. 
Values without common superscript are significantly different (P<0.05). 
 
 
 
 
 
 
 
Table S3. Mating trials 
 
 
154 
 
Table S4. Mating trials 
Variable Wnt11flox/flox Wnt11flox/flox;Cyp19-Cre 
Female 6 6 
Total litters 40 40 
Total pups 289  306 
Litter size 7.23±0.16  7.65±0.38  
Values are means ± SEM. 
Values without common superscript are significantly different (P<0.05). 
 
 
 
Variable Control 
Wnt5aflox/-;Wnt11flox/-; 
Amhr2cre/+ 
Wnt5aflox/flox;Wnt11flox/flox
;Cyp19-Cre 
Female 5 7 6 
Total litters 31 26 34 
Total pups 240 127 241 
Litter size 7.74±0.37a 4.88±0.82b 7.09±0.47a 
Values are means ± SEM. 
Values without common superscript are significantly different (P<0.05). 
 
 
 
 
 
 
Table S5. Mating trials 
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Chapter 5. General 
discussion and conclusion 
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5.1General discussion 
Infertility is an important issue that affects many couples from all over the world. 
Beside human society and medicine, infertility is also a major concern for the agriculture 
industry, and is a source of major economic losses. Achieving a better understanding of 
basic molecular and cellular events that control follicle development should lead to 
improvements in infertility treatments, such as in vitro fertilization. 
Recent descriptive studies have demonstrated the regulation of canonical WNTs 
and WNT signaling component in the adult ovary. Gonadotropins have been shown to 
regulate expression of several members of WNT signaling family, suggesting the 
importance of WNT members during follicle development (Hsieh et al., 2005, Hsieh et al., 
2002, Hsieh et al., 2003, Ricken et al., 2002).  However, little attention has been paid to 
the role of non-canonical WNTs in the ovary. Different animal models provide a 
comprehensive approach for determining the mechanisms underlying follicle development 
and fertility. For the first time, we investigated the function of WNT5a (a well known non-
canonical WNT) in the granulosa cells of two different mammalian species, the mouse and 
the cow, taking advantage of the strengths and offsetting the weaknesses of each model.  
This research helps to increase basic knowledge about the roles of non-canonical WNT 
signaling, in the hopes of increasing our understanding of infertility issues in human and 
large animal species. Many aspects of follicle development in the cow render this species 
a good model for the study of ovarian function in women. Humans and cattle are both 
mono-ovular species with similar patterns of follicular wave emergence. In addition, wave 
numbers during the menstrual cycle and dominant follicle selection and ovulation 
processes appear to be similar (Baerwald et al., 2003). Pritpal et al. have shown that the 
cow is a valid model to study reproductive aging in women (Malhi et al., 2005). 
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Furthermore, milk production is a major agricultural industry in Canada, mainly in 
Ontario and Québec (www.dairyinfo.gc.ca). The dairy industry is presently suffering a 
major decline in fertility, which has been attributed to decreased follicle and oocyte 
quality due to increasing milk production over the last two decades (Buckley et al., 2014, 
Lucy, 2007b). 
The development of transgenic mouse technology has expanded our understanding of 
ovarian physiology and follicle development, which can help to uncover possible causes 
of human fertility disorders. Using the mouse as an animal model has several advantages 
such as short generation time, a large number of pups per litter, immediate post partum 
estrus after giving birth, economy of mouse husbandry and the ability to manipulate the 
mouse genome with methods like transgenesis and knockouts (Jorgez et al., 2005).  
WNT5a is a representative example of non-canonical WNT members, and has 
been extensively studied in different cell types. WNT5a is conserved in a wide variety of 
species from C. elegans to human and it is known to regulate many aspects of cellular 
functions including cell proliferation, differentiation, polarity, adhesion and migration. A 
loss of function of WNT5a (Wnt5a-/-) resulted in perinatal lethality and a complex 
phenotype due to an inability to extend the embryonic anterior-posterior and proximal-
distal axes in outgrowth tissues (Yamaguchi et al., 1999). Recent reports suggested that 
postnatal abnormalities in Wnt5a signaling could cause cancers, inflammatory diseases, 
and metabolic disorders (Kikuchi et al., 2012). In addition, meiosis is completely inhibited 
in the ovary of WNT4/5a double mutant embryos, indicating the importance of WNT5a in 
female germline development before birth (Kikuchi et al., 2012, Naillat et al., 2010).  
In mammals, 19 different WNT proteins have been described (Hsieh et al., 2002, 
Ricken et al., 2002). Due to recent publications describing the roles of WNT4 and WNT2 
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in rodent granulosa cells, we expected these two WNTs to play important roles in the cow 
ovary as well. However, the expression level of WNT4 and 2 transcripts was very low in 
bovine granulosa cells, in contrast with WNT4 expression in human luteinized granulosa 
cells and rodent ovaries (Hsieh et al., 2003, Sanchez et al., 2014) and WNT2 expression in 
bovine granulosa cells cultured under luteinizing conditions and rodent granulosa cells 
(Castanon et al., 2012c, Ricken et al., 2002). Differences in WNT4/2 expression between 
species may reflect differences in the role of WNTs and may also be due to differences in 
the stages of follicle development and differentiation between studies. In a previous 
bovine study (Castanon et al., 2012c), granulosa cells were cultured under luteinizing 
conditions, which was in contrast with the non-luteinized system used in the present study. 
Indeed, cells in this model can respond to physiological doses of FSH and IGF1 and 
produce estrogen, mimicking growing and early antral stage follicles (Gutierrez et al., 
1997, Silva and Price, 2000). To assess Wnt5a mRNA levels in the mouse, we used an 
immature mouse model in which animals were treated with (FSH-mimetic) eCG for 48h, 
followed or not by (LH-mimetic) hCG. Our results showed that graded doses of FSH 
could decrease WNT5a mRNA and protein levels in cultured bovine granulosa cells; 
however, Wnt5a mRNA abundance increased in response to gonadotropins throughout 
follicle development in the mouse model. Beyond species differences, these contradictory 
results may also be due to the very different nature of the samples that were compared: the 
bovine granulosa cells were cultured from growing secondary and antral follicles over 6 
days in vitro, whereas the mouse granulosa cells were freshly isolated from preovulatory 
follicles. The absence of oocytes in the bovine culture system may also have altered the 
WNT5a response to gonadotropins, due to the loss of interaction between germ cells and 
somatic cells.  
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To evaluate WNT5a function in vivo, we used a conditional knock out approach. 
We used the well established Amhr2 and Cyp19 Cre-loxP models to circumvent the 
embryonic lethality of Wnt5a-/- mice and eliminate WNT5a expression specifically in 
granulosa cells. Amhr2-Cre mice express Cre in granulosa cells of all stages of follicle 
development (Fan and Richards, 2010), whereas Cre expression in Cyp19-cre mice is 
limited to antral follicles (Stocco, 2008a). With the two granulosa cell-specific knockout 
models we could study the role of WNT5a in a follicle stage-dependent manner. 
In the cow model we found that WNT5a mRNA abundance was reduced in 
dominant follicles relative to subordinate follicles, suggesting a link between WNT5a 
expression and follicle atresia. In addition, our results showed that estradiol secretion (a 
marker of healthy follicles) was significantly reduced when cultured cells were challenged 
with WNT5a. However, when we knocked out Wnt5a in mouse granulosa cells, we found 
that the proportion of antral follicles undergoing atresia increased considerably, as did 
serum estradiol levels. Our results obtained in cow model can be attributed to the 
reduction in CYP19A1 and FSHR mRNA levels, which are responsive to FSH (Luo and 
Wiltbank, 2006, Silva and Price, 2000). Inhibition of the estrogenic pathways is a 
characteristic of atretic follicles (Grimes and Ireland, 1986, Rodgers and Irving-Rodgers, 
2010), and therefore we expected WNT5a to play a role in atresia. Atresia of bovine 
follicles is associated with reduced proliferation and increased death of granulosa cells, 
which may occur through apoptotic or nonapoptotic pathways (Irving-Rodgers et al., 
2001). However, in the cow model, WNT5a did not increase the rate of apoptosis or alter 
the cell cycle in vitro, suggesting that, by itself, WNT5a is not able to induce apoptosis in 
FSH-stimulated granulosa cells in vitro. 
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How to explain our finding that the knockout of Wnt5a in granulosa cells can 
cause apoptosis? One possibility is that the increase in estradiol synthesis with higher 
expression of Cyp19a1 and Fshr can enhance secondary follicle development and early 
differentiation of granulosa cells, in a manner that is asynchronous with the development 
of the oocyte. Follicle development requires a coordination of growth and differentiation 
of the germ cells and somatic cells (Carabatsos et al., 2000). Loss of this coordination 
could result in the loss of gap junctions and connections between the somatic and germ 
cells, ultimately leading to follicle atresia. However, changes in gap junction components 
and follicular cell polarity caused by WNT5a loss were not studied in our model and 
remain to be elucidated. Our microarray data derived from cultured mouse granulosa cells 
indicated that the mRNA levels of many genes related to late stages of follicle 
development, oocyte maturation and cumulus expansion were up- or down-regulated in 
response to WNT5a, therefore a second possibility is that atresia in the Wnt5a conditional 
knockout is the result of oocyte development defects. Based on our results in the cow and 
in the mouse, loss of WNT5a appears to be a consequence of atresia rather than a cause. 
As mentioned above, WNT5a activates the CTNNB1-independent pathways 
(Kikuchi et al., 2012, Zhu et al., 2014). Based on our results in article 1, WNT5a is able to 
activate the MAPK8 signaling pathway in bovine granulosa cells. However, in article 2, 
we were not able to find any significant alteration in the PCP and WNT/Ca2+ signaling 
cascades in the Wnt5a conditional knockout mouse model. These results showed that 
WNT5a can activate different signaling pathways according to species, cell type and 
probably stage of follicle growth. An important consideration is that the cow study was 
conducted using granulosa cells extracted from small antral follicles, whereas the mouse 
granulosa cells were isolated from immature mice treated with eCG, which promotes 
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follicle development to the preovulatory stage. Therefore, there is a possibility that the 
difference we observed in these two models arises from the different stages of follicle 
development that were studied.  It seems likely that the results that we obtained in mice 
are mostly related to the role of WNT5a in ovulation, whereas in cow they relate to 
secondary and early antral stages of follicle development. Additional studies of the role of 
WNT5a in early stages of follicle development in the mouse model will be required to 
better clarify the potential role of WNT5a at the secondary to antral transition or even 
earlier in follicle development. Importantly, in addition to non-canonical signaling, non-
canonical WNTs act to suppress canonical WNT signaling (Pourreyron et al., 2012, Sato 
et al., 2010). In both the bovine and murine primary cultured GC models, we were able to 
see a drastic reduction in CTNNB1 expression in response to WNT5a, indicating that this 
is a mechanism of WNT5a action that is conserved across species and throughout follicle 
development. Different mechanisms have been proposed to explain how WNT5a can 
suppress canonical signaling. FZDs are the receptors of both canonical and non-canonical 
WNTs, resulting in a competition between them to bind to these receptors (Bryja et al., 
2009, Mikels and Nusse, 2006). WNT5a can increase SIAH ubiquitin ligase expression, 
resulting in the degradation of CTNNB1 (Topol et al., 2003). The other possible 
mechanism is that WNT5a can also activate retinoic acid-related orphan nuclear receptor α 
(RORα) via PKC, which inhibits the canonical pathway most likely by inhibiting 
coactivator recruitment to the promoters of target genes (Lee et al., 2010). If any or all of 
these mechanisms mediate the suppression of CTNNB1 in response to WNT5a in 
granulosa cells remains to be determined. 
This basic research suggests potential applications for WNT5a for the treatment of 
ovarian disorders and cancer. Altered Wnt5a expression has been linked to ovarian cancer 
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(Ford et al., 2014, McDonald and Silver, 2009). It has been shown that activation of the 
WNT/β-catenin pathway causes granulosa cell tumors (GCTs) (Boerboom et al., 2005). 
As mentioned above, some studies had reported that WNT5a can also act as an antagonist 
of canonical WNTs (Blagodatski et al., 2014). Therefore, WNT5a may have a therapeutic 
use to suppress canonical WNT signaling in patients with GCT. 
Premature ovarian failure (POF) is a condition which the ovarian reserve is 
depleted prematurely. POF has a spontaneous origin and a genetic etiology (Kuo et al., 
2011). One of the major phenotypes of Wnt5aflox/-;Amhr2cre/+  mice was a depletion of the 
ovarian reserve that resembles POF. A recent study determined that failure in Wnt5a 
signaling inhibited meiosis in the ovary during embryonic development (Naillat et al., 
2010). Together, these results showed the critical importance of Wnt5a not only during 
embryogenesis, but also after birth and in the adult. Wnt5a can control follicle 
development and survival, and seems to coordinate Wnt5a granulosa cell and oocyte 
growth in the developing follicles. Therefore, Wnt5a may play a role in POF, however we 
need to investigate its exact role.   
The present study increases our knowledge of non-canonical WNT signaling in 
granulosa cells, however further studies are needed to determine if WNT5a coordinates 
granulosa cell and oocyte growth. Moreover, the potential role of WNT5a in processes 
such as ovulation, oocyte maturation, cumulus expansion, luteinization, steroidogenesis 
and proliferation has to be investigated. 
An important area of future investigation will be to determine the relevance of our 
findings to human ovarian disorders. The role of WNT5a in ovarian cancer, POF and other 
dysfunctions has to be investigated. In addition, the potential of using WNT5a as a 
therapeutic agent to control canonical WNT signaling has to be determined. 
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5.2 Conclusion: 
In conclusion, the present study provides novel insight into the role of WNT5a and 
its mechanisms of action in two different animal models. For the first time, our data 
demonstrated that WNT5a is essential for normal follicle development. We determined 
that WNT5a negatively regulates steroidogenesis by antagonizing canonical WNT 
signaling. Our results reveal the essential role of a non-canonical WNT during follicular 
development and identify a novel pathway that regulates gonadotropin action in granulosa 
cells. 
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